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ABSTRACT
A-kinase anchoring proteins (AKAPs) are signaling scaffolds which provide
spatial and temporal organization of signaling pathways in discrete subcellular
compartments. Through tethering the cyclic-AMP dependent protein kinase A (PKA),
AKAPs target PKA activity to distinct regions in the cell, bringing PKA in close
proximity to its target proteins. This provides a high level of specificity and regulation
of PKA and its role in mediating a number of biological processes, one of which is cell
migration. Cell migration is a highly dynamic and fundamental process, when
misregulated can lead to a number of pathologies. The process of cell migration
requires integration and coordination of actin cytoskeletal dynamics, adhesion turnover,
and contractility. The important role of PKA in regulating the cellular processes
involved in cell migration has been extensively studied. Our lab has shown that PKA
activity and spatial distribution through AKAPs are localized to the leading edge of
migrating cells and are required for effective cell migration, yet the specific AKAPs
responsible remain unknown.
Traditional methods for identifying AKAPs suffer from a number of limitations.
Therefore the objective of the enclosed work is to establish and characterize a novel
approach for the identification of cytoskeletal and adhesion-associated AKAPs. We
show for the first time, an in vitro approach to identify cytoskeletal AKAPs which may
be responsible for localizing PKA to the leading edge of migrating cells.
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CHAPTER 1: Literature Review
1.1 Cell Migration
1.1.1 Introduction to Cell Migration
Cell migration is a fundamental process involved in many essential biological
processes such as wound healing, embryogenesis, and the immune response. When left
unregulated, aberrant cell migration can lead to autoimmune diseases and cancer cell
metastasis (Vincente-Manzanares and Horowitz, 2011). Cell migration is a highly
dynamic process, which involves the interplay between tension sensing, contractility,
cytoskeletal dynamics, and adhesion turnover, all converging on directional cell
movement. The involvement of cell migration in a number of fundamental biological
processes underscores its importance and the need for tight spatiotemporal coordination
and integration of many proteins and signaling pathways. While the field has
significantly advanced our working knowledge of cell migration over the past few
decades, furthering our understanding of the mechanisms underlying cell migration is
critical.
1.1.2 Basic Mechanisms of Cell Migration
Currently, cell migration is viewed as a cyclical process (Ridley et al., 2003)
and involves four steps: protrusion, adhesion to extracellular matrix, retraction, and
translocation (Howe, 2004). Directional cell migration is initiated by an extracellular
signal, which results in a dynamic reorganization of the actin cytoskeleton leading to
protrusion of the cell (Parsons et al., 2010). These protrusive structures can be broad
1

and large lamellipodia, characterized by the branching of actin filaments, or are long,
thin cables called filopodia. Protrusions make contact with the extracellular matrix,
forming focal adhesions, stabilizing the protrusive structures (Zamir, 2001; Geiger
2011). Cell migration continues through the utilization of the contractile machinery,
which among other things promotes disassembly of focal adhesions at the trailing edge
of the cell, promoting directional migration (Figure 1) (Vincente-Manzanares et al.,
2007).

Protrusion)
Filopodium)

Nascent)Adhesion)
Lamellipodium)

Ac4n)Filament)
Focal)Complex)
Focal)Adhesion)

Lamellum)
Dorsal9ventral)
actomyosin)bundle)
or)ﬁlament)

Nucleus)

Figure 1: Structural elements of a migrating cell
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Directional cell migration requires cellular polarity, which means the molecular
mechanisms at the leading edge (the front) and the trailing edge (the back) of the cell
are different. Establishing and maintaining cell polarity is mediated by the integration
of many proteins including Rho family GTPases, phosphoinositide 3-kinases (PI3Ks),
actin polymerization, integrins, actin, microtubules, myosin II, and cAMP-dependent
protein kinase A. While the molecular mechanisms that govern cell migration are
generally consistent between cell types, the relative contributions of signals depend on
the specific stimulus and cell type.
Cell migration is largely driven by changes in the cytoskeleton and interactions
with the extracellular matrix (ECM) through complexes of structural and signaling
proteins referred to as focal adhesions. This dynamic process is tightly regulated
through a number of biochemical and mechanical signaling pathways.

1.1.3 The Cytoskeleton
The cytoskeleton is the cellular architecture and is responsible for establishing
cell shape, providing mechanical strength, and cell motility. It is made up of three
molecules, actin, microtubules, and intermediate filaments. While the role of actin and
microtubules in cell migration has been well established, the contributions from
intermediate filaments have not been defined.
1.1.3.1 Actin and Actin Dynamics
Actin filaments are comprised of monomeric globular, G-actin subunits which
bind to one another through a process driven by ATP hydrolysis (Vincente-Manzanares
3

and Horowitz, 2011). Actin polymerization is the process by which ATP bound G-actin
is hydrolyzed to ADP+Pi and a bond is formed between actin subunits. The ADP+Pi
stabilize the subunits creating filamentous actin, F-actin, the stable filaments
responsible for the cellular integrity. Actin filaments are polarized structures,
displaying a fast “barbed” end, the site of new subunit incorporation, and a “pointed”
end, the origin of the growing filament (Korn et al., 1987; Carlier et al., 2003). There
are a number of different types of actin filaments, whose formation is regulated through
the number of actin filaments and the available accessory proteins. The different
morphologies give rise to different structures at distinct subcellular locations and can be
characterized as lamellipodia, filopodia, or stress fibers (Mattila et al., 2008; Mejillano
et al., 2004).
In lamellipodia, actin is arranged in large, broad, branched structures, the
assembly of which is catalyzed by the ARP2/3 complex (Pollard and Borisy 2003;
Mitchison and Cramer 1996). This complex binds to the sides of the growing actin
filament, promoting the formation of a new filament, creating a branched network of
actin filaments. Lamellipodia are followed closely with the lamellum, where the actin is
more closely bundled (Ponti et al., 2004 ). This comprises the protrusions at the leading
edge of cell, which in combination with contractile forces push the membrane forward
resulting in directional migration.
In contrast, filopodia, are long, thin cable-like protrusions which initiate from
the plasma membrane. They have been described as ‘antennae’ that cells use to probe
their local environment (Mattila et al., 2008). Protrusion of filopodia is thought to occur
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through filament tread milling, which involves attachment of actin subunits and
elongation at the barbed end, while releasing actin from the pointed end (Glenney et al.,
1981).
1.1.3.2 Actin Binding Partners
Building different morphologies of actin filaments, requires an extensive
network of accessory proteins. These are intimately involved in not only the regulation
of actin cytoskeletal dynamics, but are critical in tension sensing, mechanotransduction,
and signal transduction. There are over 100 known actin binding partners, and while the
purpose of this review is not to talk in detail about them, a few are of particular note.
As mentioned before, the Arp2/3 complex is responsible for actin polymerization in the
lamellipodia (Pollard and Cooper 2009). Activation of the Arp2/3 complex is localized
by the Wiskott-Aldrich syndrome protein (WASP/WAVE) family members (Pollard
and Borisy, 2003). Profilin binds actin monomers and prevents self-nucleation, while
helping target the monomers to the barbed end of the growing filament (Ridley et al.,
2003). The elongation of actin filaments is regulated by capping proteins such as
cofilin, which also aid in severing filaments and promoting actin dissociation (Ridley et
al., 2003). There are a number of proteins, which help to crosslink and stabilize the
actin network such as cortactin, filamin A, and α-actinin (Pollard and Cooper 2009).
Filopodial structures have additional proteins, which are enriched such as the
Ena/VASP proteins, which antagonize capping and branching and thus promote
continuous elongation of filaments. Additionally, fascin helps to bundle actin filaments

5

and is thought to help generate the stiffness needed to propel the plasma membrane
forward in filopodial-mediated protrusion (Pollard and Cooper 2009).

1.1.3.3. Rho Family GTPases
Rho family small guanosine triphosphate (GTP)-binding proteins (GTPases)
comprise a family of molecular switches, which control many signaling pathways
required for a number of cellular processes. GTPases are relatively small enzymes
whose primary role is to hydrolyze the gamma phosphate from guanine-5-triphosphate
(GTP) and are conformationally regulated by the binding of GTP and GDP. In their
inactive form, they are bound to GDP, and are activated once GDP is exchanged with
GTP. GTPase activity is mediated through a balance between guanine nucleotide
exchange factors (GEFs) and GTPase-activating proteins (GAPs) and is tightly
regulated. GTPases have been implicated in a number of aspects of cell migration,
including the control and formation of leading edge actin structures such as filopodia
and lamellipodia, and in the coordination of adhesion structures.
The first report of Rho family GTPases regulating cell migration came in 1995,
when Rho, Rac, and Cdc42 were identified (Nobes and Hall 1995). While all part of the
same superfamily, Rho, Rac, and Cdc42 all have slightly different roles with respect to
their regulation of cell migration. Rho primarily controls contractility-dependent
processes including the formation or stress fibers (Brahmbhatt and Klemke 2003).
Both Rac and Cdc42 mediate actin polymerization through their interactions
with WASP/WAVE family of Arp2/3 complex activators (Ridley and Cooper 2009).
6

Rac drives lamellipodial protrusion formation through activation of WAVE/Scar
protein through biding of an intermediate protein, IRSp53 (Cory and Ridley 2002). This
in turn regulates the activity of the Arp2/3 complex, controlling the formation of actin
structures at the leading edge. It has been shown that Rac activation is localized to the
leading edge of protruding and migrating cells (Aoki et al., 2004; Kraynov et al., 2000).
Additionally, Rac affects the migratory machinery through its activation of several
effector proteins such as PAKs, MLCK, RLC, LIMK, and stathmin (VincenteManzanares et al., 2007).
Cdc42 is the primary regulator among the Rho GTPases of cell polarity and is
active towards the front of migrating cells (Itoh et al., 2002). Cdc42 binds WASP
proteins, which stimulates Arp2/3 complex to induce branched actin polymerization.
Cdc42 also exerts its effects on cell polarity through organization and localization of
the microtubule-organizing center (MTOC) (Rodriguez et al., 2003). One downstream
target of Cdc42 is PAK1, which itself can regulate Cdc42, creating a positive feedback
loop (Ridley et al., 2003).
1.1.3.4 Myosin II
Myosins are a class of actin-binding molecules, which are often referred to as
motor proteins (Aguilar-Cuenca et al., 2014). The globular head of the myosin binds
actin and also has ATPase activity, which causes conformational movements which
allows the myosin to slide along the actin filament, generating contractile forces
(Warrick and Spudich, 1987). The affinity for actin changes, depending on the stage in
ATP hydrolysis (Clarke and Spudich, 1977). The role of non-muscle myosin II (NMII)
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has been well characterized as playing a central role in the cellular response to
mechanical cues, because of its inherent ability to generate mechanical forces (AguilarCuenca et al., 2014). Myosin II also cross-links the actin cytoskeletal and facilitates
reorganization of lamellar actin through its interactions with formin and alpha-actinin
(Choi et al., 2008). Myosin II motors have been shown to regulate focal adhesion
morphology during the maturation process (Stricker et al., 2013). Myosin II activity is
controlled by phosphorylation at several sites, the most important being Ser19 (Ikebe,
2008). A number of kinases known for their involved in migration and adhesion
dynamics have been shown to be responsible for this phosphorylation. Additionally,
cAMP-protein kinase A, Rho-associated kinase (ROCK) and integrins have been shown
to regulate the activity of myosin II.

1.1.4 Cell Adhesion
Cellular migration requires stabilization of leading edge protrusions via
interactions with their extracellular matrix. Cell-matrix adhesions are not simply static
structure, but are highly dynamic and are under tight spatial and temporal control.
Through this tight regulation, signaling proteins dictate the location, duration, and type
of cell-matrix adhesion. Cell-matrix adhesions connect the cytoskeleton through the
cytoplasmic domains of adhesions receptors, creating contact with the extracellular
matrix, and allowing cells to create a stable and force-generating contact point. By
using myosin II-mediated contractile forces, cells are able to translate the mechanical
forces felt at adhesion sites into intracellular biochemical signals. This translational
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process called mechanosensing (Schiller and Fassler, 2013). The mechanical tension at
sites of adhesions, is responsible for promoting the maturation of adhesions (Balaban et
al., 2001).

1.1.5 Importance of Cellular Adhesion
The deregulation of adhesion assembly and disassembly is common to many
diseases. Of particular note is cancer, where the regulation of cell adhesion is critical to
a cell’s ability to successfully detach and invade distal sites of metastasis. The ability of
a cell to sense and respond to its local environment, migrate, and invade distal sites are
dependent on the proper regulation of adhesion. Large scale genetic and proteomic
studies have shown many adhesion proteins to be abnormally regulated during tumor
progression (Hoffman et al., 2011).

1.1.6 Structure of Adhesions
Cell matrix adhesions were first described over 40 years ago (Curtis, 1964)
however it took a number of years to elucidate their structure and function. Over the
past few years, progress has been made in our understanding of the proteins involved at
sites of cell-matrix adhesions, as well as the types of adhesive structures. More
recently, focal adhesions have been isolated and shot-gun proteomics has been used to
identify the constituents (Kuo et al., 2012; Zaidel-Bar and Geiger 2010; Schiller et al.,
2011). Within the past four years, three-dimensional super-resolution fluorescence
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microscopy has been used to understand the architecture of focal adhesions
(Kanchanawong et al., 2010).
There are four classic types of adhesive structures, which can exists in a single
cell at any one time; nascent adhesions, focal complexes, focal adhesions, and fibrillar
adhesions (Puklin-Faucher and Sheetz, 2009; Zaidel-Bar and Geiger, 2010). The
components of adhesions has been characterized over the past few years, and over 200
different molecules have been found to associate with adhesions (Zaidel-Bar et al.,
2007) and proteins from a variety of families have been identified including
cytoskeletal proteins, transmembrane receptors, and signal transduction molecules. The
critical role adhesions play in diverse cell processes underscores their importance and
the need for further characterization.

1.1.7 Adhesion Dynamics
Adhesion dynamics are tightly regulated and is a highly dynamic process
involving continual assembly-disassembly. Adhesion of a protruding cell edge begins
with the formation of a nascent adhesions in the lemmellipodium (Parsons et al., 2010).
These are short lived and quickly turnover into focal complexes and eventually into
focal adhesions which reside at the ends of large actin bundles (Gardel et al., 2010).
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1.1.8 Focal Adhesion Components
As mentioned before, focal adhesions serve as the link between the actin
cytoskeleton and the ECM, interpreting extracellular cues and converting them into
intracellular signals. Their important function requires a complex array of molecules
and recent proteomic and bioinformatics approaches have identified over 150 proteins
associated with focal adhesions (Zaidel-Bar and Humphries 2007; Humphries et al.,
2009). Central to focal adhesions are the major transmembrane receptors, integrins. The
host of proteins at sites of focal adhesions come from a host of different molecular
classes including cytoskeletal proteins, kinases, modulators of small GTPases,
phosphatases, and other enzymes (Zamir and Geiger, 2001). Many of these proteins
directly bind to actin or the cytoplasmic tails of integrins, while others transiently
associate with adaptor/scaffolding proteins. Because of the diversity and breadth of
protein-protein interactions at sites of focal adhesions, they have become a site for
organization of multi-protein signaling complexes. The list of focal adhesion proteins is
extensive and therefore this review will discuss a selected group of proteins drawn from
each of the major families of proteins.

1.1.8.1 Scaffolding Proteins
Focal adhesions contain several proteins that function as signaling scaffolds for
the components of focal adhesions. This provides a mechanism by which signaling
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enzymes can associate with their substrates and leads to changes in cell morphology
and behavior. In addition to p130Cas and Crk, paxillin is one of the best described
scaffolding proteins at focal adhesions (Webb et al., 2004). Paxillin has a number of
motifs that facilitate its binding to signaling proteins such as Src, FAK and PKL (Webb
et al., 2004). It also contains C-terminal LIM domains which allows it to attach to the
cell membrane and interact with the phosphatase PTP-PEST (Turner 2000).
Recruitment to focal adhesion complexes is mediated by binding to the β1 and α4
integrin cytoplasmic tails (Liu et al., 2002).
Phosphorylation of paxillin is important for focal adhesion formation and
maturation. For example, paxillin phosphoryatlion on Y31, Y119, or S273 results in
robust protrusion and focal adhesion assembly in protrusions (Nayal et al., 2006,
Zaidel-Bar et al., 2007). Additionally, in vivo data shows that the phosphorylation of
paxillin leads to complex formation with FAK to regulate dynamics of nascent
adhesions (Choi et al., 2011) and phosphorylation by FAK and Src lead to the creation
of addition binding sites for adaptor proteins (Turner 2003). Paxillin has also been
implicated to inhibit α4β1-dependent cell migration through its binding to α4 integrin
tail (Goldfinger et al., 2003).
Paxillin acts as a critical component of focal adhesions through its activation of
Rho family GTPases. Both Cdc42 and Rac co-localize with paxillin and stimulate the
activity of p21-activated kinase (PAK) (Manser et al., 1998). Activated PAK in turns
modulates the actin cytoskeleton into lamellipodia and filopodia formation (DelormeWalker et al., 2011).
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1.1.8.2 Signaling Proteins
Phosphorylation is one of the key signaling events that occur at focal adhesions,
both at tyrosine and serine/threonine sites. Tyrosine phosphorylation at focal adhesions
has been well characterized as providing binding sites for SH2-containing proteins thus
regulating the activation of many signaling kinases and phosphatases (Webb et al.,
2004). There are a number of tyrosine kinases such as focal-adhesion kinase (FAK),
Src, Abl, and Csk as well as serine/threonine kinases such as PAK and PKC that are
found in focal adhesions (Zamir and Geiger, 2001). While these all have important
roles in regulating adhesion dynamics and cell behavior, FAK is one of the best
characterized and therefore will be the focus of the subsequent section.
FAK is a tyrosine kinase which localizes to focal adhesions via its C-terminal
focal adhesion targeting domain (FAT) (Hildebrand et al., 1993). It is centrally
positioned for regulating focal adhesion dynamics through its association with talin,
providing the link between integrin-mediated signal transduction and subsequent
downstream pathways (Chen et al., 1995). It phosphorylates a number of targets
involved in adhesion dynamics (Chen et al., 1995) and therefore has evolved as one of
the central and most important regulators of signaling complexes at focal adhesions.
Phosphorylation at Y397 has been shown to result in the recruitment of Src-family
PTKs, which in turn causes Src-mediated phosphorylation and thus creating further
binding sites for proteins such as Grb2 (Schlaepfer et al., 1999).
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The requirement for FAK in cell migration has been demonstrated through
experiments showing that fibroblasts from FAK-null mice exhibit a decreased rate of
migration and an increase in the number of size of adhesions (Ilic et al., 1995). FAK’s
role in adhesion turnover has been further characterized and recently it has been shown
that FAK-Src signaling regulates adhesion disassembly through ERK and MLCK
(Webb et al., 2004). Furthermore, FAK has been implicated in cancer cell invasion and
studies with human tumor tissues and tumor-derived cell lines have shown FAK
expression to be high (Cance et al., 1995). Furthermore, FAK recruitment and
activation are associated with integrin clustering, and FAK complexes with proteins
such as talin, have been shown to regulate focal adhesion turnover (Lawson et al.,
2014).
FAK also plays a role in regulating adhesion dynamics through its activation of
small GTPases by binding and phosphorylating their exchange factors (Webb et al.,
2004). Given the role of small GTPases in regulating adhesions, further highlights the
importance of FAK in focal adhesion dynamics.

1.1.8.3 Integrins
Integrins are one of the major transmembrane receptors central to adhesions.
They play a structural role linking the actin cytoskeleton to the extracellular matrix
(ECM) and mediate all cell-ECM interactions. Integrins also serve as a major site for
transmission of mechanical and biochemical signals from the ECM to the inside of the
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cell. Many cellular processes rely on signal cascades organized by proteins interacting
with the cytoplasmic tail of integrins.
Integrins are comprised of non-covalently associated α and β-glycoprotein
subunits, which pass the membrane through a single membrane helix (Lad et al., 2007).
Combinations of the α and β-chains form the 24 different heterodimers, which
contributes to the diversity of integrins and ultimately enabling cells to respond to
different extracellular cues (Geiger and Zaidel-Bar, 2012). The integrin heterodimer is
entirely dependent on the ECM ligand present surrounding the cell. Upon binding the
extracellular ligand, a conformation change occurs allowing assembly of multi-protein
complexes and thus initiating downstream signaling pathways. Because integrins
contain no enzymatic activity, they rely on the recruitment of signaling enzymes for
proper signal transduction.
The cytoplasmic tail has been shown to bind to at least 12 different adaptor
proteins including tensin, filamin A, talin, plectin, paxillin, talin, and α-actinin (ZaidelBar, 2007a). Further links to the actin cytoskeleton occur through second and third tier
scaffolds such as, paxillin-actopaxin, kindlin-1-migfilin-VASP (Zaidel-Bar, 2007a).
Maintaining the integrin-actin connection is critical to the function of adhesions,
specifically with respect to mechanotransduction.
Integrin activation is the process defined by the switching of affinity for ECM,
from that of low to that of high affinity state. In addition to the ECM itself, integrins
can be regulated by a number of cytoplasmic proteins. The binding of talin has now
been characterized as the final step in integrin activation (Calderwood et al., 2013) and
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the binding of talin to integrins is a highly regulated process as well (Morse et al.,
2014). Kindlin is another protein, which plays a role in integrin activation, while
creating additional binding sites for other proteins involved in adhesion dynamics
(Brahme and Calderwood, 2012; Brahme et al., 2013; Tu et al., 2003). The critical role
of integrins requires their activity to be tightly spatial and temporally controlled. In
addition to direct integrin activators, integrins have also been shown to be negative
regulated by proteins binding to the cytoplasmic tails (Morse et al., 2014). Filamin A, is
a large actin-cross linking protein is one of the most well characterized integrin
inhibitors. Through competition for binding to the integrin β-tail with talin and kindlin1, filamin A has been shown to suppress integrin activation (Kiema et al., 2006; Shifrin
et al., 2009; Takala et al., 2008). Phosphorylation of filamin A has been shown to
modulate the interaction with integrins, and thus their activity. Of particular note is
regulation of integrin binding through phosphorylation at Ser2152 (Chen et al., 1995).
The multi-protein signaling complexes that form around integrins are
responsible for transmitting signals from integrins and regulating the cytoskeletal
dynamics involved in cell migration and adhesion. As mentioned before, there are tiers
of proteins, which help connect the actin cytoskeleton to integrin cytoplasmic tails.
Proteins such as talin and filamin A are particular important in this connection as they
have been shown to induce conformational changes under tension, strain, and stretching
(Ehrlicher et al., 2011; Chen et al., 2009; Nakamura et al., 2009; Nakamura et al.,
2007). Furthermore, force applied across filamin actually causes release of the
filaminA-associated Rho GTPase activating protein (FilGAP), which allows for another
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level of regulation of the cytoskeleton (Ohta et al., 2006). Integrins are also able to
affect cytoskeletal dynamics through regulation of Rho family GTPases although these
signaling pathways are beyond the scope of this dissertation.

1.1.8.4 The Integrin Adhesome
Advances in technology over the past decade have allowed for the visualization
of dynamic focal adhesion turnover and cytoskeletal dynamics. It is therefore widely
appreciated that the proteins assembled at sites of integrins and focal adhesions are in
constant flux. Currently, there are 156 components (Zaidel-Bar et al., 2007a,b) with an
even larger number of direct protein-protein interactions. As the field begins to uncover
the complexity and connectivity of the integrin adhesome, it has become clear that in
order to provide both strong adhesions and dynamic turnover, the proteins present at
any one time must change (Zaidel-Bar et al., 2007a). Due to the extensive network of
protein-protein interactions, it is likely that a snap-shot of the cell at one time would
only show proteins binding a fraction of their binding partners. This combined with
differences in tissue and cell type expression, contribute to the diversity of signals
which are transduced. Even more, proteins may interact with different binding partners
within the same cell and even within the same adhesion, furthering the complexity of
the adhesion networks that are possible.
The complex of proteins assembled at integrins and adhesions must be tightly
regulated in order to exert a specific function. Regulation can occur through protein
conformation, changes in temperature, pH or ion concentration, binding of proteins, or
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post-translational modifications (Zaidel-Bar et al., 2007a). It is also likely that force
acts to play a role in altering the profile of proteins involved in the integrin adhesome
by causing conformational rearrangements in molecules exposing and hiding discrete
binding sites. This has been shown recently in single-molecule stretch experiments of
both talin and filamin A, known integrin binding partners (del Rio et al., 2009; Chen et
al 2009).
As the extensive network of proteins, which make up the integrin adhesome
unfolds, the mechanisms and regulation of these complexes become impossible to
follow. What is clear however, is their importance in regulating important cellular
processes including cell migration through numerous signaling pathways. One
signaling pathway of particular importance is the cAMP dependent protein kinase A
pathway, which the remainder of this work will focus on.
Signaling events are regulated through a variety of mechanisms but one of the
most widely used is phosphorylation. Phosphorylation is the process in which a gamma
phosphate is transferred from adenosine-triphosphate to its substrates in a mechanism
called phosphorylation. Protein phosphorylation is a covalent, yet reversible,
modification of proteins, which regulates many cellular functions. Almost every
signaling pathway includes protein kinases and in commonly, protein phosphatases,
which act to remove the phosphate group. Phosphorylation has diverse roles, and the
presence of a phosphate group can affect enzymatic activity of proteins, induce
conformational changes, target proteins for degradation, create docking sites for
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subsequent proteins to bind, and mediate protein-protein interactions. Phosphorylation
is one of the most widely used regulatory mechanisms in eukaryotic organisms.

1.2 cAMP/PKA Signaling

1.2.1 Structure and Function of PKA
The cAMP-dependent protein Kinase-A (PKA) is one of the most well
characterized signaling enzymes in the cell, and whose role has been implicated in a
number of cellular processes. In its inactive form, PKA is a heterotetrameric enzyme
comprised of two regulatory (R) and two catalytic (C) subunits. There are two types of
PKA holoenzyme, defined either as RI or RII. There are four types of R subunits,
encoded by four genes (RIα, RIβ, RIIα, RIIβ) and only three genes encoding the C
subunits (α, β,	
   and	
   γ). The regulatory subunits function to maintain holoenzyme
integrity, facilitate N-terminal dimerization, provide a mechanism for A-kinase
anchoring, and release the catalytic subunits upon binding of cAMP (Howe, 2004).
Upon binding two molecules of cAMP to the regulatory subunits, a conformational
change occurs releasing the catalytic subunits, which are then free to phosphorylate a
number of downstream substrates.
PKA is a serine threonine kinase, which phosphorylates proteins at a conserved
consensus site, RXXS/T (where X is any amino acid). PKA has a diversity of
substrates, drawn from many functional classes including nuclear proteins, cytoplasmic,
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mitochondrial, and cytoskeletal. Regulation of PKA is a well characterized mechanism
through which activation of G-protein coupled receptors are coupled to the G-protein,
Gαs, which activates downstream effectors such as adenylate cyclase to convert ATP to
cAMP (Ross et al., 1977). PKA’s activity is dependent on the local concentrations of
cAMP. As a second messenger itself, there is tight spatial control of cAMP and it’s
availability is regulated through adenylyl cyclase and phosphodiesterases (PDEs).
Additionally, specific PDE isoforms have been shown to be coupled to specific GPCRs,
which allows for a tight level of regulation surrounding cAMP degradation (Benedetto
et al., 2006). The conversion of cAMP to AMP by phosphodiesterases represents one
of the feedback mechanisms responsible for down-regulation of PKA.

1.2.2 Cellular Distribution of PKA
Type I and type II R subunits have differential tissue distribution and even
differential subcellular localization. While type I PKA is localized in the cytoplasm, the
majority of type II PKA is localized to subcellular compartments, through binding to Akinase anchoring proteins, which will be discussed in greater detail later. Additionally,
the R subunits have different affinities for cAMP, which allows for different thresholds
of activation. Because of the breadth and cellular distribution of PKA substrates, there
is a large need for its activity to be regulated within the subcellular space. Both through
anchoring and localized cAMP gradients, there is a dynamic level of regulation to PKA
activity, allowing for the organization of spatial signaling cascades in response to
specific stimuli.
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1.2.3 Role of PKA in Cell Migration
The role of PKA in cell motility has been studied extensively and well
characterized as both required for, and detrimental to cell migration (Edin et al., 2001;
Ydrenius et al., 1997). PKA exerts both positive and negative effects to control
adhesion, membrane protrusion and retraction, and cytoskeletal dynamics as many
processes require its activity while others are inhibited (Howe, 2004). While the role of
PKA in cell migration has been reviewed extensively (Howe, 2004), a few of the
findings will be presented below.

1.2.3.1 Negative Regulation
PKA has been shown to negatively affect aspects of cell migration. One of the
classic examples shows that PKA causes inhibition of α5β3-mediated endothelial cell
migration (Kim et al., 2000). Similarly, Spina et al., reported that PKA inhibits leptininduced migration of breast cancer cells (Spina et al., 2012). While PKA’s negative
regulation of integrin-mediated cell migration has been well characterized, recently it
has been shown that PKA may inhibit bladder cancer cell invasion through targeting of
MAP4-dependent microtubule dynamics (Ou et al., 2014). Additionally, it was recently
shown that increased levels of PKA activity, achieved through an increase in cAMP
levels, inhibits migration and invasion of pancreatic ductal adenocarcinoma cells
(Burdyga et al., 2013). Central to cell migration are actin cytoskeletal dynamics. PKA
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has been found to inhibit the formation of actin stress fibers in endothelial cells (Liu et
al., 2001). These observations represent a few mechanisms by which PKA is able to
inhibit cell migration.

1.2.3.2 Positive Regulation
The requirement and positive effects for both, elevation of cAMP and activation
of PKA, in cell migration have been well characterized for a number of cell types. It
was found over a decade ago, that PKA was required for growth-factor stimulated
migration of fibroblasts (Edin et al., 2001), and this finding became monumental in
establishing PKA’s role in migration. Subsequently, PKA has been found to facilitate
leading edge dynamics, specifically PKA activity is required for pseudopod stability
and formation (Howe et al., 2005), and is required for the formation and attenuation of
actin-induced membrane ruffles (Howe et al., 2008). Filopodial and lamellipodial
formation, additional mechanisms of protrusion, were also shown to require PKA
activity (Grieshaber et al., 2000; Plopper 2000). Most recently, PKA activity was found
to be localized to the leading edge of migrating epithelial ovarian cancer cells and
inhibition of activity prevented migration (McKenzie et al., 2011).
While the mechanism by which PKA contributes to cell migration has yet to be
completely elucidated, it is important to point out that PKA has been shown to be
important or necessary to many processes central to cell migration. For example, PKA
has been shown to play a role in regulating a number of small GTPases intrinsic to actin
cytoskeletal dynamics and cell migration such as Cdc42 (Feoktistov et al., 2000), Rac
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(O’Connor et al., 2001), RhoA (Tkachenko et al., 2011; Chen et al., 2005), and Rap1
(Takahashi et al., 2013). Additionally, PKA activity has been shown to be required for
cell migration through its regulation of α4-integrins (Lim et al., 2008; Goldfinger et al.,
2003).
It has become increasingly clear that the PKA activity observed at the leading
edge of cells does not simply have a negative or positive effect on cell migration.
Instead, PKA activity is tightly spatially and temporally regulated such that it is able to
exhibit an oscillating regulation over the mechanisms of cell migration.
1.2.4 The Role of PKA in Cell Adhesion
As mentioned prior, the reciprocal regulation between PKA activity and
integrins is beginning to be defined (Lim et al., 2008, Goldfinger et al., 2003) thus
providing evidence for the role of PKA in cell adhesion. PKA has been shown to be
activated not only in response to integrin-mediated cell-ECM adhesion, but also by
cellular detachment (Whittard et al., 2001; O’Connor et al., 2001; Howe et al., 2002).
The activation and inactivation of PKA was actually shown to be both cell type and
ECM-ligand specific (Whelan et al., 2003). This was shown when PKA activity was
suppressed in endothelial cells plated on collagen I, thus engaging α1β1	
   integrins, but
not on laminin-1 (Whelan et al., 2003). Additionally, the dichotomous regulation of
PKA was shown through two experiments which showed that adhesion through the β1	
  
integrin suppresses PKA activity during α5β3-mediated endothelial cell migration yet
activates PKA in carcinoma cells and fibroblasts (Howe et al., 2002; O’Connor et al.,
2001).
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The connection between PKA and cell-ECM adhesion is further supported by
the reports of the reciprocal regulation between PKA activity and the α4	
   integrin
(Goldfinger et al., 2003; Lim et al., 2004; Lim et al., 2008). Of particular note is the
finding that the cytoplasmic tail of the α4	
   binds type I PKA in a mechanism distinctly
different from canonical A-kinase anchoring interactions, which will be discussed in
detail later (Lim et al., 2008). This localized PKA activity was actually shown further
by the finding that the PKA-induced phosphorylation of the α4	
   cytoplasmic	
   tail	
   was	
  
completely	
  localized	
  to	
  the	
  leading	
  edge	
  of	
  lamellipodia	
  and	
  absent	
  from	
  the	
  rear	
  
of	
  migrating	
  cells	
  (Goldfinger	
  et	
  al.,	
  2003).	
  This	
  was	
  followed	
  up	
  by	
  the	
  finding	
  that	
  
this	
  phosphorylation	
  was	
  necessary	
  for	
  α4β1-mediated migration (Goldfinger et al.,
2003).

1.2.5 Substrates of PKA in Regulation of the Cytoskeleton, Adhesion, and Migration
The role of PKA in cell migration has been further defined by the identification
of numerous substrates intimately involved in cytoskeletal dynamics, adhesion, and
actomyosin contractility. These phosphorylation events have been shown in proteins
borrowed from structural and signaling classes, representing the breadth of targets in
which PKA exerts its effects to regulate migration. The list of PKA targets involved in
migration is extensive and has been well reviewed before (Howe, 2004), therefore the
subsequent section will cover a fraction of the relative targets in an effort to
demonstrate PKA’s importance in regulating cell migration.
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As mentioned previously, of particular note and certainly integral to migration
and adhesion, the cytoplasmic tail of the α4	
   integrin, has been shown to be directly
phosphorylated by PKA (Lim et al., 2004; Lim et al., 2008).

1.2.5.1 Actin
One of the most elegant examples of PKA’s role in regulating aspects of cell
migration is exemplified through the direct phosphorylation of actin (Ohta et al., 1999).
Furthermore it was shown that this phosphorylation led to the decreased ability of actin
to polymerize (Ohta et al., 1999). While this mechanism has not been further defined, it
does demonstrate a direct connection between PKA and the actin cytoskeleton. There
are many ways other, which PKA regulates actin dynamics, which have been well
characterized, and will be discussed subsequently.

1.2.5.2 Vasodilator-stimulated phosphoprotein (VASP)
The vasodilator-stimulated phosphoprotein (VASP) is a member of the
cytoskeletal regulatory binding protein family Ena/VASP. These proteins contain
several domains including an N-terminal EVH-1 domain, a C-terminal EVH-2 domain,
and a central proline-rich domain (Howe et al., 2002). These domains enable VASP
family proteins to localize to focal adhesions through binding to vinculin, zyxin, and
actin itself (Reinhard et al., 2001; Krause et al., 2003; Grange et al., 2013).
Additionally, VASP family proteins are thought to be required for filopodial formation
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as they directly and indirectly associate with actin-capping proteins and cross-link actin
filaments (Lebrand et al., 2004; Breitsprecher et al., 2011; Pasic et al., 2008). Three
phosphorylation sites on VASP have been linked to both PKA and PKG, although Ser153 has been well characterized as the preferred site for PKA, and has been shown to
correspond to a decreased ability to nucleate, bind and bundle actin filaments
(Lambrechts et al., 2000). Furthermore it has been shown that the phosphorylation of
VASP may disrupt its interactions with additional binding proteins, suggesting a further
role for PKA in regulating the assembly of critical proteins involved in regulating
adhesion dynamics (Lambrechts et al., 2000).
1.2.5.3 Myosin Light Chain (MLC)
Non-muscle myosin II is one of the critical regulators of the actin cytoskeleton
during cell migration through myosin-contractility and is important for not only leading
edge dynamics, but also retraction at the rear edge of the cell (Vincente and Horowitz,
2004). The phosphorylation of myosin through myosin light chain (MLC) regulates its
activity, specifically the binding to F-actin and myosin-based contractility (Howe). The
phosphorylation state of MLC is largely regulated through MLC kinase (MLCK) and
MLC phosphatase (MLCP) activity, and PKA has been implicated in playing a role in
this dynamic (Verin et al., 1998; Garcia et al., 1997). Although the role of PKA in
regulating the aforementioned is complex, it nonetheless highlights the central role of
PKA in cell migration through regulation of a protein central to actin dynamics.
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1.2.5.4 Filamin A
Filamin A is an important regulator of actin cytoskeletal dynamics. Filamin A
acts to promote orthogonal branching of the actin-cytoskeleton by binding, stabilizing,
and bundling F-actin (Razinia et al., 2012). Filamin A is localized to both the
protruding and retracting edge of migrating cells (Zhou et al., 2010), linking the
cytoskeleton to the cell membrane and providing mechanical stability to cells. In
addition to binding actin, filamin A has been shown to interact with over 90 diverse
cellular proteins, allowing filamin A to act as a scaffolding protein and integrating
multiple signaling pathways (Zhou et al., 2010).
Extensive work has been done to demonstrate the role of Filamin A in cell
adhesion and migration (Kim et al., 2008). As eluded to before, Filamin A has been
shown to localize to filopodia, lamellipodia, stress fibers, and focal adhesions
(Campbell 2008). Additionally, filamin A-deficient melanoma cells (M2) exhibit
decreased motility and decreased adhesion stability (Lynch et al., 2011; Cunningham et
al., 1992; Baldassarre et al., 2009). Filamin A also regulates integrin-mediated
lamellipodial formation and extension and cell spreading on collagen in a number of
cell types (Kim et al., 2008, Byfield et al., 2009).
Filamin A has been shown to have over 90 binding partners, borrowed from
many functional classes, yet a number of which are intimately involved in cytoskeletal
dynamics and adhesion . Of particular interest is the binding to β-‐integrins,	
  which	
  as	
  
described	
   earlier,	
   are	
   essential	
   to	
   both	
   cell	
   migration	
   and	
   adhesion	
   (Lim	
   et	
   al.,	
  
2008).	
  Filamin	
  A	
  was	
  actually	
  found	
  to	
  regulate	
  cell	
  spreading	
  via	
  the	
  β1-‐integrin,	
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suggesting	
  that	
  filamin	
  A	
  may	
  modulate	
  β1	
  integrin	
  activity	
  directly	
  and	
  through	
  
the	
   recruitment	
   of	
   additional	
   proteins	
   (Byfield	
   et	
   al.,	
   2009;	
   Kim	
   et	
   al.,	
   2010).	
  
Filamin	
  A	
  has	
  also	
  been	
  shown	
  to	
  bind	
  to	
  Rho	
  Family	
  GTPases	
  and	
  some	
  of	
  their	
  
regulators	
   (Stossel	
   et	
   al.,	
   2001),	
   specifically	
   Rac,	
   Rho,	
   Cdc42,	
   and	
   RalA	
  
(Baldassarre	
  et	
  al.,	
  2009).	
  Even	
  more,	
  it	
  was	
  shown	
  that	
  the	
  interaction	
  between	
  
Filamin	
  A	
  and	
  RalA	
  were	
  required	
  for	
  RalA-‐induced	
  filopodial	
  formation	
  (Ohta	
  et	
  
al.,	
   1999).	
   Filamin	
   A	
   has	
   also	
   been	
   shown	
   to	
   bind	
   downstream	
   effectors	
   such	
   as	
  
PAK1	
   (Vadlamudi	
   et	
   al.,	
   2002)	
   and	
   ROCK	
   (Ueda	
   et	
   al.,	
   2003).	
   While	
   the	
   list	
  
continues	
   of	
   filamin	
   A	
   associated	
   binding	
   partners,	
   these	
   partners	
   alone	
   provide	
  
strong	
  evidence	
  to	
  support	
  filamin’s	
  role	
  in	
  cytoskeletal	
  dynamics	
  and	
  adhesion.	
  	
  
Interestingly enough, filamin A has also been shown to be a phosphorylation
target of PKA (Jay et al., 2000). Subsequent studies showed that this phosphorylation
event occurs in filamin’s C-terminus at Ser2152 and Thr2336 (Jay et al., 2004). While
the role of these phosphorylation sites has yet to be completely determined, it is thought
to have some protection over filamin cleavage (Garcia et al., 2006).

1.2.5.5 Rho Family GTPases
The roles of Rho family small GTPases have been extensively studied and
reviewed, and therefore a brief summary will be included below.
Recently, a role for PKA was identified in regulating protrusion-retraction
cycles at the leading edge of cells. Specifically, the phosphorylation of RhoA on Ser188
by PKA was critical in controlling migration events at the leading edge of cells
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(Tkachenko et al., 2011). This evidence showed an alternative mechanism for PKA as
it had previously been shown to negatively regulate RhoA through Rho-GDI (Qiao et
al., 2008). Furthermore, over-expression of AKAP-Lbc, which will be discussed in
more detail later, showed an increase in Rho-mediated stress fiber formation likely by
coupling to PKA through the G-protein Gα12 (Diviani et al., 2001). Thus this
mechanism perfectly exemplifies anchorage-mediated PKA regulation over cytoskeletal
proteins.
PKA activity is required for both the activation of Rac and Cdc42 (O’Connor et
al., 2001; Bachmann et al., 2013; Feoktistov et al., 2000). Previously, Rac activity has
been observed to be localized to the leading edge structures in migrating or protruding
cells (Aoki et al., 2004). Work from our lab has shown that in fact inhibition of PKA
activity inhibited Rac activity through the regulation of Rac-GAP and Rac-GEF (Howe
et al., 2005). Unlike RhoA however, Rac is not directly phosphorylated by PKA.
However, it was recently found that Rac1 shows AKAP properties and showed a direct
interaction with PKA type IIβ	
   subunits	
   (Bachmann	
   et	
   al.,	
   2013).	
   This	
   provides	
  
evidence	
   for	
   the	
   localization	
   of	
   PKA	
   within	
   protein	
   complexes	
   involved	
   in	
  
cytoskeletal	
  dynamics	
  and	
  cell	
  migration.	
  	
  	
  
The examples above were given do not fully encompass the multitude of PKA
substrates however they were intended to give examples of a subset of targets that are
intimately involved in actin cytoskeletal dynamics and adhesion. As the evidence for a
role of PKA in cell migration is surmountable, an underlying mechanism is still to be
elucidated. This mechanism is likely to be very complex, and tightly spatially and
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temporally regulated. This spatial control is achieved through compartmentalization of
PKA to distinct subcellular locations through a family of scaffolding proteins called Akinase anchoring proteins (AKAPs). Thus anchoring allows spatial control of PKA
signaling by regulating proximity to its specific substrates in discrete subcellular
locations as well as providing temporal control through localizing PKA to small
pockets of cAMP activity. Understanding which AKAPs are responsible for PKA
anchoring during cell migration and adhesion is of critical importance to understanding
the mechanism by which PKA is regulated during these fundamental processes.

1.3 A-Kinase Anchoring Proteins

1.3.1 The Importance of Scaffolding Proteins
Cells respond to and convert cues from the extracellular environment to
intracellular effects through the use of signaling proteins. Many signaling proteins have
broad substrate specificity, which requires a precise level of regulation to achieve
efficacy and accuracy. Scaffolding proteins are one of the key mechanisms by which
the cell coordinates and regulates signaling events. Classically, scaffolding proteins
were defined as proteins which tether signaling enzymes, promoting their
communication by proximity, while binding a number of other molecules acting as
platforms for the assembly of signaling complexes (Alexa et al., 2010). More recently,
regulatory roles for scaffolding proteins have been defined using basic mechanisms
such as proximity, combinatorial binding partners, conformational fine-tuning of pre30

existing signaling cascades, and offer feedback and feed-forward regulation. One of the
most appreciated aspects of scaffolding proteins is the ability to create tight spatial and
temporal organization of signaling complexes, enabling the cell to not rely on simple
passive diffusion, as a means of transmitting signaling events. One family of well
characterized, yet diverse, scaffolding proteins are the A-kinase anchoring proteins
(AKAPs).

1.3.2 Introduction to A-Kinase Anchoring Proteins
As mentioned before, PKA activity has been seen at the leading edge of
migrating cells (McKenzie et al., 2011). AKAPs are responsible for the sequestration of
PKA to these subcellular locations, organizing signaling complexes, and bringing PKA
within close proximity to target proteins. Additionally, AKAPs are adaptors, which
allow for the integration of a number of other signaling molecules, providing a
mechanism for cross talk among diverse signaling pathways.
AKAPs provide a tight spatial and temporal control, which in turn provides
enhanced specificity in signal transduction pathways. AKAPs do not only act to direct
PKA in the cell, but they also couple PKA to its upstream and downstream regulators
such as adenylyl cyclases and phosphodiesterases. These provide both positive and
negative control while creating intracellular cAMP gradients culminating in stimulusspecific activation of PKA.
The remainder of this review will focus on the description and characterization
of AKAPs, their mechanism of binding PKA, and their role within cellular dynamics.
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Particularly, this review will focus on methods to identify and characterize new
AKAPs.
1.3.3 AKAP Structure and Function
AKAPs are a structurally diverse, but functionally similar family of proteins
that now includes over 50 family members (Tasken et al., 2010). While AKAPs share
little primary sequence similarities, they all contain a highly conserved secondary
structural element, which facilitates their binding to PKA. All AKAP family members
contain three structural elements; a conserved helical PKA anchoring domain, binding
sites for additional signaling molecules, and subcellular localization signal (Carnegie et
al., 2004).

1.3.4 AKAP Nomenclature
Initially, AKAPs were named for their molecular weight identified by SDS gel
electrophoresis. For example, AKAP79 can be found at 79 kDa in SDS-PAGE.
However after finding that many AKAPs were fragments and smaller transcripts of
larger genes, AKAPs were renamed using a sequential numbering system. The most
recently identified AKAPs such as Ezrin, Rab32, and WAVE-1 have not been included
in the numbering classification (Pidoux and Tasken, 2010).
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1.3.5 Localization Signals
The ability for AKAPs to target PKA and other signaling molecules to distinct
subcellular regions impinges on each AKAP’s individual targeting motif. AKAPs have
been found to associate to different subcellular compartments, including the plasma
membrane, mitochondria, nuclear membrane, and cytoskeleton (Figure 2). In some
cases, several different AKAPs can be targeted to the same location. For example, both
AKAP79/150 and Gravin, also known as AKAP250, are both targeted to the plasma
membrane through phospholipid-binding sequences (Dell’Acqua et al., 1998; Grove
and Bruchey 2001). Gravin however, is thought to contain an additional N-terminal
myristoyl group as well (Grove and Bruchey 2001). AKAP18 is thought to target to the
plasma membrane however this is through dual myristoyl and palmitoyl groups (Trotter
et al., 1999). AKAP350 and pericentrin are targeted to the centrosome through a motif
named the pericentrin-AKAP350 centrosomal targeting domain (PACT) (Diviani et al.,
2000; Gillngham and Munro, 2000). At the mitochondria, D-AKAP1, Rab32, and
WAVE1 are all localized, however while Rab32 and WAVE1 are targeted through the
prenylation of cysteine residues at their C-termini, D-AKAP1 is localized through a
more conventional mitochondrial targeting sequence (Huang et al., 1999; Alto et al.,
2002; Danial et al., 2003). Although the subcellular location of many AKAPs has been
identified, the details and specific targeting motifs have only been identified for a few
molecules. The presence of multiple AKAPs within the same subcellular compartment
suggests the need for multiple and distinct signaling complexes within one region of the
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cell. This mechanism acts to provide tight signaling regulation by enabling PKA to
phosphorylate a different panel of substrates within the same subcellular location.
In some cases, splice variants arising from the same gene are often targeted to
different subcellular compartments. For example, AKAP18 is differentially spliced into
three isoforms, alpha, beta, and gamma (Trotter et al., 1999; Fraser et al., 1998), and
each isoform has distinct subcellular distribution. Additionally, AKAP350 can be
spliced into shorter and longer isoforms (Trotter et al., 1999). The shorter isoforms are
directed to synaptic membranes, binding to the NMDA receptor, where the longer
isoforms are directed to the centrosome through the C-terminal PACT domain (Schmidt
et al., 1999; Witczak et al., 1999).
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Figure 2: AKAP Signaling Complexes Localize to Distinct Subcellular Regions to Create Focal
Points for Signal Transduction
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1.3.6 Mechanism of PKA Anchoring
One of the defining characteristics of AKAPs is the mechanism by which they
bind PKA regulatory subunits. This binding occurs through a 14-18 amino acid
sequence, which forms a highly conserved amphipathic alpha-helix (an alpha-helix with
opposing polar and nonpolar faces) (Carr and Scott, 1992). The helix coils such that the
hydrophobic residues of the helix contact the grove formed by the RII dimers (Figure 3)
(Carr and Scott, 1992). AKAP-PKA interactions have been elucidated using AKAP
derived peptides and the dimerization domains of PKA RIIα subunits.

Figure 3: Overview of Structures of RII Dimerization Domain in Complex with an
Amphipathic AKAP Helix (Adapted from Gold, MG., Lygren B., Dokurno, P., Hoshi, N.,
McConnachie, G., Tasken, K., Carlson, CR., Scott, JD., and Barford, D. Molecular basis of AKAP
specificity for PKA regulatory subunits. Molecular cell 24, 383-395 (2006))

The conserved amphipathic helix was first identified over 20 years ago through
sequence comparisons between some of the first identified AKAPs, Ht31, Map2, Ht21,
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and P150. While sequence comparison revealed little overall homology, all RIIα
binding regions revealed a conserved glutamic acid at position 3. Comparing the polar
and nonpolar residues in these regions, showed a strong alignment of types of
hydrophilic and hydrophobic residue types (Figure 4). Furthermore, when using a
helical wheel projection for each of the sequences, hydrophilic and hydrophobic amino
acids became grouped on opposing faces of the helix. No other sequences in the
proteins could be similarly aligned, suggesting the functional significance of these
regions within each of these proteins (Carr et al., 1991). Mutagenesis of amino acid
residues within the putative RIIα binding region of Ht31 disrupted the secondary
structure of the helix and abolished PKA binding, highlighting the importance of the
helical structure (Carr et al., 1991). Furthermore, introduction of proline residues
outside of the putative PKA binding region had no effect on binding. The amphipathic
helix motif is conserved throughout the AKAP family with the exception of pericentrin
(insert refs). NMR structural analysis confirmed the helical structure of the AKAP RIIα
binding domain when in complex with the RIIα dimer (Newlon et al., 2001).
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Figure 4: Sequence Alignment and Conservation of Hydrophilic and Hydrophobic Residues
Among Known AKAPs

Of equal importance in PKA anchoring is the requirement of PKA regulatory
subunit dimerization. The AKAP binding region was identified in the N-terminus of the
RIIα subunit. Preliminary experiments in which RII mutants lacking the first 14, 30, or
35 residues resulted in the inability to bind the well characterized AKAP, MAP2 (Scott
et al., 1990). Further characterization revealed that disrupting RII dimerization resulted
in abolished binding to MAP2, showing the requirement for RIIα dimerization in PKA
anchoring. It is now known that residues 1-44 of RIIα are highly conserved and that
dimerization is maintained within this region (Scott et al., 1987; Dell’Acqua et al.,
1998; Newlon et al., 1999). Triple resonance, three-dimensional nuclear magnetic
resonance techniques further characterized the highly conserved residues 1-44 of RIIα
revealing the dimerization structure. This analysis in conjunction with crystal structures
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of the RIIα dimerization domain showed the formation of a four-helix bundle with two
protomers forming an antiparallel conformation with their N-termini (Gold et al.,
2006; Newlon et al., 1999; Newlon et al., 2001; Kinderman et al., 2006). This wellordered four-helix structure is maintained through extensive hydrophobic interactions
(Figure 5) (Newlon et al., 1999). These hydrophobic residues are also responsible for
creating the extended hydrophobic grove of the RIIα dimer interface, necessary for
AKAP binding. Mutations in hydrophobic residues in either the RIIα dimer or within
the AKAP RIIα binding domain diminish or abolish binding, suggesting the importance
of the hydrophobic residues for maintaining PKA anchoring (Miki and Eddy, 1999).
Specifically, mutagenesis studies identified isoleucines at position 3 and 5 within the
RIIα dimerization domain that are important for AKAP binding (Hausken et al., 1994;
Hausken and Scott, 1996).
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Figure 5: Details of the AKAP Helix-RIIα Dimerization Domain Polar Contacts (Adapted from
Gold, MG., Lygren B., Dokurno, P., Hoshi, N., McConnachie, G., Tasken, K., Carlson, CR., Scott,
JD., and Barford, D. Molecular basis of AKAP specificity for PKA regulatory subunits. Molecular
cell 24, 383-395 (2006))

1.3.7 Type I vs. Type II Anchoring
While the majority of AKAPs identified to date bind PKA type II, type I
binding has been well established and characterized. Additionally, dual-specificity
AKAPs (D-AKAPs) are able to bind both type I and type II regulatory subunits (Huang
et al., 1997; Huang et al., 1999). Many dual-specificity AKAPs, while able to bind both
types of subunits, often bind RI subunits with 10-100-fold lower affinity than RII
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(Welch et al., 2010). For example, binding assays of D-AKAP1 with all four isoforms
of PKA revealed binding to RIIα and RIIβ at KD=0.5nM compared to a KD=185nM for
RIα and RIβ (Stokka et al., 2006). Rate constants for AKAP79 binding to all four
regulatory subunits were also identified revealing higher affinity binding to RIIα and
RIIβ, indicating this is not unique to D-AKAP1 (Stokka et al., 2006).
NMR structural analysis of the RIα dimerization domain reveals some subtle
structural differences between RIα and RIIα within the N-terminus. The structure of the
RIα dimerization domain (D/D) is similar to that of RIIα, forming the four-helix bundle
with the major difference existing at the extreme N terminus. Within the RIIα dimer,
the extreme N-terminus is extended (Newlon et al., 1999; Newlon et al., 2000), where
in RIα it forms a helical structure (Banky et al., 2000). This helical structure partially
occludes the AKAP binding surface and is therefore responsible for the observed
differences in AKAP binding among RIα and RIIα (Banky et al., 2003). Further
characterization of the RIα extreme N-terminus shows this region to contain more
charged residues than that of RIIα (Banky et al., 2000) disrupting the hydrophobic
groove of the AKAP binding surface. The presence of these charged residues within the
AKAP binding region provides evidence for an alternative RIα AKAP binding
mechanism, which involves stabilization through acidic and basic residues with the
addition of an electrostatic component (Burns et al., 2003). Solution structures of the
D/D of RIα showed the formation of a deep cleft maintained by disulfide bonds in
contrast to the hydrophobic groove formed by the D/D of RIIα (Banky et al., 2003;
Sarma et al., 2010).
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It was recently shown that dual-specificity AKAPs contain an additional PKA
binding element, which is located outside of the conserved amphipathic helix (Jarnaess
et al., 2008). In vitro binding experiments with the dual-specific AKAP ezrin, identified
this region as the RI specifier region upstream of the canonical helix (Jarnaess et al.,
2008). Sequence alignments of other known dual-specificity AKAPs including DAKAP1, D-AKAP2, PAP7, and Merlin revealed the presence of this conserved region.
Furthermore, classical RII AKAPs such as AKAP-Lbc and AKAP79 do not contain this
region, suggesting the specificity for RI binding (Jarnaess et al., 2008).

1.3.8 Noncanonical AKAPs
Not all AKAPs bind to the dimerization domain through an amphipathic helix
(Skroblin et al., 2010). There are a few noncanonical AKAPs which have been
identified, however few are known likely due to the fact that they are missed in screens.
Pericentrin is the best characterized noncanonical AKAP, whose binding to PKA RIIα
is facilitated through a non-helical, 100 amino acid, leucine-rich region (Diviani et al.,
2000). Additionally, the α4 integrin cytoplasmic domain, which is not predicted to form
an α-helix, interacts with type I PKA in a manner that is not disrupted by Ht31
disruptor peptides (Lim et al., 2007). This suggests a noncononical mechanism of PKA
anchoring. It is possible that this noncanonical binding may provide an additional level
of PKA regulation and the potential for many AKAPs to be uncovered.
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1.3.9 Evolution of AKAPs
The majority of the currently identified AKAPs have been found from human or
rat origin (Scott et al., 2013). However, orthologs of a number of mammalian AKAPs
were also found in lower vertebrates such as Xenopus (Isoldi et al., 2010; Klingbeil et
al., 2001; Park et al., 2007; Semenova et al., 2009) and Danio rerio (Goehring et al.,
2007; Reynolds et al., 2007). AKAPs have also been identified in invertebrates such as
the nematode Caenorhabditis elegans and the fruit fly Drosophila melanogaster (Angelo
and Rubin, 1998). AKAPs have even been identified in the unicellular green algae,
Chlamydomonas reinhardtii (Gaillard et al., 2001). There is little known about AKAPs
in invertebrates, and it is most likely that there are a larger number of AKAPs
expressed in vertebrates. Thus giving rise to their role in the regulation of large
signaling processes required for specialized cell functions and cell-cell communications
in complex multicellular organisms. The current knowledge shows the mechanism of
PKA anchoring is similar across species, suggesting the highly conserved and
indispensable role for AKAPs.

1.3.10 AKAPs as Organizers of Multivalent Complexes
While the most appreciated and biologically significant role of AKAPs is their
interaction with PKA, an additional feature of these molecules is their ability to bind a
number of other signaling enzymes. Thereby allowing AKAPs to form multivalent
signaling complexes. In many cases, AKAPs bind enzymes with opposing actions such
as kinases and phosphatases, defining their role as regulators of both signal transduction
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and signal termination. Two of the most well characterized examples of this are
AKAP79 and AKAP220, as they bind to PKA and either calcium-calmodulindependent phosphatase (PP2B, also known as calcineurin) (Klauck et al., 1996) or
protein phosphatase 1 (Schillace et al., 1999) respectively. Furthermore, AKAP79 has a
capacity to bind a number of other proteins involved in signaling, which allows for the
formation of customized and localized signaling complexes to the plasma membrane in
a number of different cell types (Carr et al., 1992). Targeting enzymes to the cell
periphery therefore positions them in a way, which enables them to respond to pools of
intracellular second messengers such as cAMP, calcium, and phospholipids. In fact,
AKAP79 has been shown to be one of the anchoring proteins, which targets PKA to βadrenergic receptors to play a role in their phosphorylation-mediated down-regulation
(Fraser et al., 2000). AKAP79 has also been shown to physically associate with
adenylyl cyclase 5 terminating cAMP synthesis upon phosphorylation (Bauman et al.,
2006).
Multiple signaling pathways can be integrated via a single AKAP complex.
Interestingly, AKAP79/150 is also able to coordinates protein kinase C mediated
signaling events (Navedo et al., 2008). These findings suggest the flexible and dynamic
role AKAPs and their ability to be involved in a number of signaling events, allowing
for crosstalk and large coordination of multivalent complexes.
Another aspect of AKAPs is their ability to anchor enzymes to selected
substrates. This therefore facilitates signal transduction through the dual anchoring of
both enzymes and specific substrates within distinct subcellular regions. The functional
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implication of which is rapid and highly regulated signal transduction. Instead of
relying on diffusion of proteins involved in signaling cascades, AKAPs create pockets
of signaling complexes. Phosphorylation of proteins in one of the universal means of
intracellular communication and one in which requires a high level of regulation.
Although the physiological roles of anchored PKA phosphorylation events have been
elucidated in a number of cell types, the organization and operation of individual
protein complexes within AKAP complexes has yet to be defined. Even more, the
functional significance of effects on substrate phosphorylation when PKA anchoring is
disrupted has yet to be elucidated.

1.3.11 Regulation of Signaling Complexes/Context Dependent Complexes
As AKAPs are continually characterized, and their binding partners elucidated,
it has become obvious that a single anchoring protein is able to interact with only a
small subset of proteins at any given time. However, there exists great potential in the
ability to organize different enzyme combinations and therefore the repertoire of signals
that are processed through a single AKAP. This complexity can be expanded through
context specific regulation, either at specific compartments within the cell or through
tissue-specific cues.
The WAVE family of proteins (WAVE1, 2, 3) coordinate different signaling
complexes at both the compartment and tissue-specific level. For example, in neurons,
growth-factors stimulate WAVE1 bound Rac to cause actin reorganization (Miki et al.,
1998). However in hepatocytes, WAVE1 is involved in the regulation of PKA
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phosphorylation of BCL2, contributing to apoptosis (Danial et al., 2003). Within the
same cell, there is differential targeting of AKAP isoforms to distinct subcellular
locations. This allows for the regulated distribution of PKA to discrete pockets of
substrates. For example, yotaio can be associated with the plasma membrane, targeting
PKA to channels and receptors such as the NMDA receptor (Westphal et al., 1999)
while the longer splice variants are targeted to the Golgi apparatus (Shanks et al.,
2002). These vastly different mechanisms for single AKAPs within different cellular
contexts allows for the expansive roles of AKAPs and implicates their importance in
the coordination of signaling.
The recruitment and release of binding partners can also be determined by
covalent modifications, thereby modulating not only the composition of signaling
complexes but also the activity of anchored enzymes. Phosphorylation has been shown
to regulate both the binding to and release of proteins from AKAPs (Carnegie et al.,
2004; Carlisle-Michel et al., 2004; Diviani et al., 2000; Kapiloff et al., 1999).
Specifically, it has been shown that phosphorylation of PDE4D3 increases its affinity
for the anchoring protein mAKAP (Carlisle-Michel et al., 2004) while PKA mediated
phosphorylation of AKAP-Lbc disrupts its association with PKD (Carnegie et al.,
2004).

1.3.12 Disruptor Peptides as a Tool for Understanding Anchoring Function
In order to study the functional roles of AKAPs, peptides that disrupt the PKAAKAP interaction have been developed. These have been widely used in the field and
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have additionally served as important tools in the study of PKA’s functional
implications in cellular processes. All of the peptides developed comprise the PKA
binding domain of AKAPs, the 14-18 stretch of amino acids forming the amphipathic
helix. The first anchoring disruptor to be characterized was a 24 amino acid peptide
from Ht31 (now called AKAP-Lbc) which lies between residues 494-507 (Carr et al.,
1991; Carr et al., 1992). Further characterization of the Ht31 peptide showed this 24
amino acid stretch is sufficient to disrupt both PKA type I and type II anchoring
(Herberg et al., 2000). This peptide binds RIIα with low nanomolar affinity (KD=2.2
nM) (Newlon et al., 2001). Second-generation disruptors were later developed in order
to distinguish between RI and RII AKAP interactions (Burns-Hamuro et al., 2003; Alto
et al., 2002; Carlson et al., 2006; Gold et al., 2006).

1.3.12.1 Type I Specific Disruptor: RIAD
A peptide derived from D-AKAP2, a known dual-specific AKAP, was used as a
template to design a specific RIα disruptor (Burns-Hamuro et al., 2002). Truncations
and amino acid substitutions were made to identify critical residues and minimal length
requirements for bindings and regulatory subunit binding affinity was assessed by
SPOT synthesis (Burns-Hamuro et al., 2002). Using both bioinformatics and a peptide
array screening, this peptide was further characterized and a higher affinity binding
peptide called RIAD (RI anchoring disruptor) was developed which has 1000-fold
higher selectivity for type I PKA than type II PKA (Carlson et al., 2006).
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1.3.12.2 Type II Specific Disruptors: AKAP-IS and sAKAP-IS
Just as a specific type I disruptor was created, a specific type II disruptor was
also created. Through a combination of bioinformatics, screening of peptide arrays, and
RII overlay assays, a high-affinity RII binding peptide was created, called AKAP-in
silico (AKAP-IS) (Alto et al., 2003). In vitro binding assays showed that the AKAP-IS
had subnanomolar affinity for RII and was more effective at displacing RII from
AKAP79 than the Ht31 peptide (Alto et al., 2003). Furthermore, a scrambled form of
this peptide was shown to have no affect the subcellular distribution of PKA in cells
(Alto 2003). The AKAP-IS peptide was later optimized by analysis of 340 AKAP-IS
peptide derivatives where each residue in the sequence was replaced by all 20 amino
acids. RI and RII binding was assessed using RIα-P32 and RIIα-P32 overlays (Gold et
al., 2006). The resulting peptide, named SuperAKAP-IS, contained amino acid
substitutions which both increased the RII binding affinity and decreased the RI
binding affinity. This peptide, exhibits a 4-fold higher affinity for RIIα and 12.5-fold
reduced affinity for RIα compared to the AKAP-IS (Gold et al., 2006).
Modifications such as affinity tags, fluorescent dyes, or cell-penetrating tags
have been made to these peptides to expand their experimental usability. While these
peptides have been widely used experimentally, they do have their limitations. The
global disruption of PKA anchoring within the cellular context liberates PKA, creating
excessive amounts of free PKA in the cytoplasm, which can result in irregular
phosphorylation of substrates. Additionally, the modifications of these peptides can
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result in the uneven distribution within the cell, leading to their enrichment in some
subcellular locations.
1.4 AKAPs at the Cytoskeleton

1.4.1 Introduction of AKAPs at the Cytoskeleton
As mentioned earlier, the actin cytoskeleton is essential for a number of
biological processes. Our lab and others have shown that PKA is essential for cell
migration and that PKA is critical for regulating actin cytoskeletal dynamics
(McKenzie et al., 2011; Howe et al., 2004; Rivard et al., 2009). Due to the breadth of
its targets and their subcellular localization, the need for focusing and directing PKA to
specific cellular compartments is essential. Our lab has shown that PKA is spatially
regulated during cell migration, and more specifically is enriched in protrusive leading
edge structures.
There are a number of cytoskeletal proteins that have been shown to be
substrates for PKA. Additionally, the phosphorylation of which has been shown to be
essential for regulating their function, particularly in the role of cell migration. Many
hallmarks of cell migration and cytoskeletal dynamics have been shown to require PKA
activity (Rac, Cdc42, microfilament assembly), while others are inhibited by PKA
(Rho, p21 activated kinase, VASP). Integrin dependent endothelial cell migration is
both positively and negatively regulated by PKA. These observations implicate the
critical role for PKA in regulating cell migration.
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The combination of complexity of cytoskeletal dynamics, diversity and breadth
of PKA’s targets, and PKA’s role in regulating cell migration/actin cytoskeletal
dynamics underscores the importance of PKA’s localization in the aforementioned. It is
clear that PKA is neither a positive nor a negative regulator, but rather cytoskeletal
dynamics/cell migration requires a balance of PKA activity tightly spatially and
temporally regulated. Given the function of AKAPs as scaffolding proteins for multiple
signaling enzymes and as anchors for PKA, it is likely that there are AKAPs within the
cytoskeleton/adhesions responsible for anchoring PKA to sites where it can regulate
cytoskeletal dynamics/migration.

1.4.2 Cytoskeletal AKAPs
There are several AKAPs to date which have been identified as being involved
in actin cytoskeleton dynamics including, AKAP-Lbc/AKAP13 (Diviani et al., 2006;
Cavin et al., 2014; Klussmann et al., 2001), gravin (Gelman et al., 1998), ezrin
(Dransfield et al., 1997; Bosanquet 2014), and the WASp and verprolin homology
protein-1 (WAVE1) (Yamazaki et al., 2005; Takenawa 2005; Takenawa and Miki
2001).

1.4.2.1 Gravin
Gravin, also known as AKAP12, was originally identified in a screening of
endothelial cell expression library with serum from a myasthenia gravis patient
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(Gordon et al., 1992). A few years later, it was shown to be a RIIα specific AKAP
which could also bind to PKC, beta2 adrenergic receptor, PDE4D, and Ca2+/calmodulin
(Nauert et al., 1997; Fan et al., 2001; Malbon et al., 2004; Willoubuy et al., 2006). It is
now well appreciated that Gravin plays a role in cellular adhesion, migration,
cytoskeletal dynamics, and maintenance of the cytoskeletal architecture (Akakura and
Gelman 2012). The C-terminal domain of Gravin is required for targeting PKA to the
cell periphery (Yan et al., 2009). Gravin has been described as attenuating and
inhibiting chemotaxis and cell invasion (Busch et al., 2008; Gelman et al., 2000) and
likely through differential activation of both PKA and PKC (Su et al., 2013). Gravin
has also been shown to be intimately involved in FAK-mediated signaling (Gelman)
and playing a role in FAK-mediated adhesion and motility pathways (Su et al., 2013).
Even more, Gravin has been shown not only to bind to the actin cytoskeleton (Gelman
et al., 2012) but also act as regulator of its architecture, regulating the formation and
maintenance of stress fibers (Lin et al., 2000). Taken together, these observations
demonstrate the critical role Gravin plays in actin cytoskeleton dynamics during cell
migration.

1.4.2.2 WASP family verprolin homologous protein 1 (WAVE1)
WAVE1 is one of the Wiskott-Aldrich syndrome protein family members
(Takenawa and Miki 2001). WAVE1 directly binds to actin and is intimately involved
in actin dynamics, both through Rac-1 mediated actin reorganization (Miki et al., 1998)
and by coupling Rho GTPases to the Arp2/3 complex (Higgs et al., 1999; Machesky
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and Gould 1999). Recently, WAVE1 was identified as an AKAP and of particular note
is the finding that pools of WAVE1 localize from focal adhesions to sites of actin
reorganization upon PDGF treatment (Westphal et al., 2000). Furthermore, Westphal et
al., showed that upon treatment with PDGF, PKA also localizes to sites of actin
reorganization (Westphal et al., 2000). A unique feature about the PKA-WAVE1
interaction is that actin may compete for the RII binding site (Westphal et al., 2000).
The highly dynamic WAVE1-mediated complex formation is a possible mechanism
used by the cell to both regulate the activity and location of PKA and coordinate actin
reorganization thus cytoskeletal dynamics following Rac activation. Not only does
WAVE1 bind PKA RII subunits, but it also has the ability to bind the c-Abl tyrosine
kinase, forming a multi-signaling enzyme complex (Westphal et al., 2000). This dual
binding ability of WAVE1 is particularly interesting given that PKA has been shown to
phosphorylate VASP and cause its uncoupling from Abl (Howe et al., 2002) suggesting
PKA plays a central role in the regulation of complexes at sites of WAVE1 mediated
actin reorganization.

1.4.2.3 Ezrin
Ezrin is a member of a superfamily of cytoskeletal associated proteins including
merlin, radixin, moesin, and talin (Algrain et al., 1989; Bretscher et al., 2002). These
proteins share homology in their N-terminus which has been implicated in their
membrane associations (Arpin et al., 1994). Ezrin is part of a smaller subfamily of
proteins, the ERM family, including radixin and moesin, which share homology across
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the sequence (Salto et al., 2012). Experiments have shown the binding of PKA RII to
Ezrin to disrupted using the Ht31 anchoring disruptor peptide (Dransfield et al., 1997).
These results, taken with further characterization of the PKA bidning domain on Ezrin,
have identified it as a bonafide AKAP (Dransfield et al., 1997). Of particular interest is
that the C-terminal domain of ezrin has been implicated in the association with actin
filaments (Hanzel et al., 1991). Therefore it is likely that Ezrin plays a role in anchoring
PKA to the actin cytoskeletal, possibly providing an avenue for which PKA could
regulate actin dynamics.
1.4.2.4 AKAP-Lbc (AKAP13)
AKAP-Lbc is a unique cytoskeletal associated AKAP as it not only anchors
PKA but it has the ability to modulate the Rho GTPase (Klussman et al., 2001). In vitro
experiments identified AKAP-Lbc as a guanine nucleotide exchange factor (GEF) with
a specificity towards Rho and not Rac or Cdc42, implicating its ability to regulate stress
fiber and focal adhesion formation (Diviani et al., 2001). Furthermore, the Rho-GEF
activity of AKAP-Lbc was found to be bi-directionally regulated via G-protein Gα12
activation and inactivation through PKA-induced phosphorylation and 14-3-3 protein
binding (Diviani et al., 2004; O’Connor et al., 2012). Taken together this highlights a
mechanism by which PKA and Rho signaling pathways are integrated through
scaffolding via AKAP-Lbc. Given what is known about Rho’s regulation of the actin
cytoskeleton, this provides a likely mechanism for PKA’s regulation over cytoskeletal
dynamics. Further experiments demonstrated a role for AKAP-Lbc in establishing and
maintaining PKA gradients (Paulucci-Holthauzen et al., 2009). This in conjunction
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with the well-established role of compartmentalized PKA activity in cell migration
implicates AKAP-Lbc’s intimate involvement in regulating cell migration.
The multiple identified actin-associated AKAPs highlights the importance for
both PKA activity and the regulation of that activity at sites of actin reorganization and
thus processes requiring cytoskeletal dynamics. This taken together with the myriad of
known PKA substrates involved in actin cytoskeletal dynamics, adhesion, and
migration, support the critical role of PKA activity in regulating such processes.

1.5 Methods for Detecting A-Kinase Anchoring Proteins

The design of specific anchoring disruptor peptides has advanced the field’s
understanding of A-kinase anchoring and ability to identify novel AKAPs. However,
before the inception of these peptides, AKAPs were identified using more traditional
methods used, all of which had their limitations.
1.5.1 Identification of the First AKAP
The first described AKAP was microtubule associated protein 2 (MAP2) and
was found rather serendipitously as a molecule that co-purified with the regulatory
subunit of PKA on cAMP-agarose affinity columns (Theurkauf and Vallee, 1981).
Detailed study of PKA anchoring was achieved after the observation that many AKAPs
retained their ability to bind RII after transfer to nitrocellulose (Keryer et al., 1993).
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1.5.2 RII Overlay
This observation prompted the development of the RII overlay technique where
proteins are separated by SDS-PAGE electrophoresis, transferred to nitrocellulose, and
subsequently incubated with

32

P-labeled RII probe (Carr and Scott, 1992). This

technique, called a far-western or RII-overlay, is essentially a modified western blot,
and has been widely used by many laboratories for the detection of AKAPs. Extending
this technique further, Rubin and colleagues used RII to screen cDNA expression
libraries and since eight AKAPs cDNAs have been identified and characterized with
this method (Ludvig et al., 1990). These methods have their limitations however. Due
to the strong denaturing conditions used in SDS-PAGE, which causes protein
misfolding, a number of AKAPs often lose their ability to bind RII, resulting in missed
interactions.

1.5.3 Band-Shift
These limitations allowed for use of band-shift analysis as a means of
identifying AKAPs. This technique examines protein-protein interactions under nondenaturing conditions and takes advantage of the differential motility that protein
complexes exhibit compared to their individual components (Carr and Scott, 1992).
This led to the demonstration that AKAPs bind to the RII subunit, regardless of the
association with the catalytic subunit (Carr and Scott, 1992). Not unlike the far-western,
this technique has its limitations. One of which is the requirement of high
concentrations of protein for detection and the disruption of equilibrium conditions
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during electrophoresis. The combination of these techniques with the use of disruptor
peptides such as Ht31, became standard within the field.

1.5.4 Immunoprecipitation
Co-immunoprecipitations (co-IPs) and cross-linking IPs have been classically
used as a method for identifying protein-protein interactions and are often used for
characterizing PKA-AKAP interactions. Co-IPs are often used as a way to affinity
purify a protein and characterize its associated binding partners. However this approach
often misses weak, less abundant and transient interactions. Additionally, co-IP data is
commonly misinterpreted as proof of direct protein-protein interactions, and is rarely
followed up with the correct experiments to prove such a conclusion. Another
limitation to co-IPs is the stringency of the conditions under which the experiment is
taking place, which can often disrupt native protein interactions, causing them to be
undetected. Inherent in these experiments is the nature of the antibody-target
interaction, which itself is subject to harsh conditions as well as the potential, and
reality, of non-specific binding.
Chemical crosslinking and crosslinking IPs by contrast, were implemented as a
way to improve upon the traditional co-IP. Due to the formation of covalent bonds, they
are often more suitable for capturing transient and low-affinity interactions. However,
this method is highly non-specific and often results in the aggregation of multi-protein
complexes, which present solubility problems in downstream applications.

55

1.5.5 Bioinformatics
Within the past decade, bioinformatics has allowed for significant progress in
the field of AKAP identification and characterization. Bioinformatic screens in
conjunction with peptide overlays and traditional methods have allowed for large
screens leading to the identification of novel AKAPs (Hundsrucker et al., 2010). This
approach has its limitations however, one of which is the high number of false positives
detected simply through searching for proteins containing the AKAP consensus
sequence. Additionally, the presence of the canonical AKAP sequence alone does not
sufficiently provide indication of an AKAP, but instead is suggestive and further
structural considerations must to given to the sequence. More specifically, as described
previously, the consensus sequence often forms an amphipathic alpha-helix motif to
mediate PKA-AKAP binding. Searching for a simple consensus sequence search will
not take this structural requirement into consideration, therefore generating many false
positives.
1.5.6 Anchoring Disruptor Peptides
The generation of both RIAD and sAKAP (is) have allowed for the ability to
distinguish between type I and type II anchoring. However, these peptides have their
limitations as they do not allow for the contributions from individual AKPAs to be
elucidated within the cellular context. These difficulties were the impetus for
developing a structure-based phage selection strategy, which creates RII subunit
fragments with selective binding to individual AKAPs, therefore enabling the
examination of individual AKAPs (Gold et al., 2013).
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Given the limitations and antiquity of the aforementioned techniques, a need to
develop new methods with higher selectivity, specificity, and applicability within the
cellular context has been well established. This thesis aims to optimize and characterize
a new method for detecting AKAPs. Using a combination of both biochemical
techniques and large-scale proteomics, this method focuses on a novel technique to
identify putative AKAPs. This body of work describes first the application of this
technique in whole cell extract, and later extends the application to cellular
fractionations enriched with cytoskeletal and adhesion proteins to identify AKAPs
involved intimately in cytoskeletal dynamics, adhesion, and cell migration.
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CHAPTER 2: Materials and Methods
2.1 Cell Culture
SKOV-3 and HEK293 cells were obtained from American Type Culture
Collection and maintained in antibiotic-free Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% (vol/vol) fetal bovine serum (FBS). All cells for lysis
were grown in 10cm dishes coated with 10µg/µL human fibronectin at 37°C in a
humidified incubator containing 5% CO2.
2.2 Antibodies and Other Reagents
Primary antibodies were obtained commercially from Millipore (Actin C4,
filamin A), BD Transduction Laboratories (AKAP79, Ezrin, Lamin A/C, paxillin
clone349,), Cell Signaling (GAPDH), Santa Cruz Antibodies (PKA RIIα, AKAP79)
and Sigma (Tubulin DM1α). DMSO was acquired from Sigma (St. Louis, MO).
Horseradish peroxidase-conjugated secondary antibodies were from Calbiochem, with
the exception of horseradish peroxidase-conjugated streptavidin, which was from
Thermo Fisher Scientific. Human fibronectin was acquired from BD Biosciences
(Bedford, MA). Sulfo-SBED Biotin Label Transfer Reagent was purchased from Pierce
(Rockford, IL). Dynabeads® Myone ™ Streptavidin T1 beads, Dynabeads® Protein G,
and DynaMag™ were acquired from Life Technologies (Thermo Fischer Scientific).
Pharmacological inhibition of PKA anchoring was achieved using Ht31 (aka AKAPLbc) from Sigma-Genosis, a peptide comprising the PKA R-subunit binding domain.
Ht31 acts as a competitive inhibitor of the interaction between AKAPs and both RIIα
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and RIα PKA subunits (Gold). The Ht31 and Ht31P synthetic peptides contained the
sequences LIEEAASRIVDAVIEQVK and LIEEAASRPVDAVPEQVK respectively,
were diluted in MMQ H2O and stored at -20°C. IPTG acquired from Thermo Fisher
Scientific (Waltham MA). Duolink® PLA reagents were obtained from Sigma (St.
Louis, MO).
2.3 RIIα Purification
BL21 (DE5) PLysS bacteria containing pET28(b)-RIIα(WT) plasmid were
inoculated into 5mL Terrific broth containing 1x kanamycin and 34µL chloramphenicol
(from 147x stock). Inoculations were placed at 37°C shaking for 6-8 hours and
subsequently back inoculated into a 25mL culture of Terrific broth containing 1x
kanamycin and 170µL chloramphenicol (from 147x stock). Culture was let shake at
37°C shaking overnight. The following day, culture was back inoculated into a 1L
culture of terrific broth with 1x kanamycin and 6.8mL chloramphenicol (from 147x
stock) and put at 37°C shaking until OD600=0.6-0.8 (1mL of culture was removed
before induction to be used for subsequent immunoblotting and coomassie staining).
Induction of bacteria: IPTG was added to a final concentration of 1mM in
culture and let shake for 4h at 37°C. 1mL of culture was removed at each 1h interval to
be used for subsequent immunoblotting and coomassie staining. Cells were pelleted at
4,000xg for 10’at 4°C. Supernatant was removed and saved. 40mL cold lysis buffer
(recipe described subsequently) was added to pellet was resuspended. Cell suspension
was sonicated 5x10sec, with a 15sec interval between each sonication. Culture was then
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spun down at 18,000xg for 15’ at 4°C. Supernatant was removed and put on ice, pellet
was discarded.
Batch Binding: In large tube, lysis buffer and cAMP agarose beads were mixed
(5:1 v/v) (Sigma) and gently resuspended. Beads were spun at 500xg for 5’ at 4°C (or
until beads collect at bottom of tube). Supernatant was removed and this repeated two
times to thoroughly wash the beads. Lysate added to washed cAMP beads and mixed
end over end for 16h at 4°C.
Column Purification: Fresh lysis and wash buffers were made prior to start of
column preparation. cAMP lysate mixture was spun at 500xg for 5’ at 4°C to collect
beads at bottom of tube. Supernatant was removed and saved on ice, 100µL was
removed for SDS-PAGE confirmation. 10mL lysis buffer added to beads and beads
were resuspended gently. Slurry was poured into a column and beads were let settle for
1h at room temperature. Lysis buffer was run out into a small beaker, 100µL removed
for SDS-PAGE confirmation. Beads washed with 5-10 column volumes of lysis buffer,
lysis buffer+1M NaCl, 10mM MOPS, lysis buffer, 100µL removed at each wash step
for SDS-PAGE confirmation. Beads eluted with 2 column volumes 100mM cAMP
diluted in lysis buffer. Eluents were collected in 0.5mL fractions, and 10µL was
removed from each for SDS-PAGE confirmation. Fractions were frozen at -80°C until
SDS-PAGE was run to confirm purity of prep. 10µL of each fraction was mixed with
equal volumes of 2x Laemmli sample buffer and run on 10% SDS-PAGE gel. Gel was
stained with coomassie-silver stain (recipe listed subsequently) for 15’ followed by
destaining in MMQ H2O for 1h. Purity of samples was assessed and highest purity
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elution fractions were pooled for dialysis. Pooled RIIα was dialyzed in 10mM MOPS,
100mM NaCl, for 1h at room temperature, buffer changed 2x.
2.4 Conjugating RII to Sulfo-SBED
Sulfo-SBED multifunctional cross-linker (Pierce, Thermo Fisher Scientific) was
dissolved in 22µL DMSO. 5-20µg purified RIIα was conjugated to 5µL dissolved
Sulfo-SBED and incubated for 40’ at room temperature and protected from light.
Sample was passed over a desalting column (Pierce) and frozen at -80°C in between
uses.
2.5 Biotin Transfer
Lysate was “pre-cleared” as follows: 50-100µg SKOV-3 protein extract was
incubated with 2:1 v/v streptavidin magnetic beads for 1h at room temperature. Beads
were pelleted on magnet and supernatant was removed and placed into new ice cold
microcentrifuge tube. 100µM Ht31 or Ht31P was added to lysate and incubated rocking
end over end for 1h at room temperature. To lysate, RIIα-Sulfo SBED, 1:200 w/w,
covered with foil, and incubated for 45’ at room temperature rocking end over end. Foil
was removed and samples were exposed to UV light (365nm) for 30’ at room
temperature, mixing and spinning down every 7-8’ to ensure samples were thoroughly
mixed. DTT was added to a final concentration of 100mM and samples were heated at
50°C for 30’. Streptavidin magnetic beads were added to samples (after buffer
exchange in RIPA buffer), 1:2 v/v, and samples were incubated at 1h at room
temperature rocking end over end. Beads were pelleted on magnet, supernatant was
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saved and put on ice. To beads, 1mL RIPA buffer was added, vortexed, and placed on
ice for 1’. Beads were pelleted on magnet for 1’, removed wash and repeated for a total
of 4 washes. After last wash, all remaining buffer was removed and 40µL 1x Laemmli
sample buffer was added, beads were resuspended and spun down, and boiled for 10’.
Beads were pelleted on magnet for 2’ and samples were loaded directly onto 10% SDSPAGE gel.
2.6 Cytoskeletal Preparation
10cm dishes were coated with 10µg/mL human fibronectin at 37°C for 1h.
Dishes washed 3x with sterile 1xPBS prior to plating cells. SKOV-3 cells were plated
and let grow to sub-confluence (~90%) prior to lysing.
Media was removed from cells and cells were washed gently with Dulbecco’s
complete 1x PBS. 1.5mL cytoskeleton stabilizing buffer (recipe described below) was
added to side of dish, rocked gently, and incubated for 4’ on ice. Dish rocked gently
side to side and contents were pooled, and collected from bottom of dish using a P1000
pipetteman, fraction labeled “cytoplasmic fraction”. Dish washed gently with 2mL
cytoskeleton stabilizing buffer and wash discarded. 250µL RIPA buffer containing
protease and phosphatase inhibitors was added to dish, and rocked back and forth to
cover entire surface area of dish. Using a rubber police-man, dish was scraped very
gently (minimal mechanical shearing), and lysate pooled at bottom of dish. Lysate
removed carefully and spun at 100xg for 5’ at 4°C. Supernatant removed and
transferred to new ice-cold tube and labeled “cytoskeletal fraction”. 200µL 1x Laemmli
sample buffer was added to pellet (“nuclear fraction”) and heated at 75°C for 3-4h.
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2.7 In-gel Digestion and Liquid Chromatography-Tandem Mass Spectrometry (LCMS/MS)
Extracted biotin-tagged proteins were separated by 10% SDS-PAGE and stained
with coomassie blue. Following sufficient destain (50mM NH4HCO3 and 50%
acetonitrile (MeCN), the no RIIα lane, and +/- Ht31 peptide lanes were each cut into 10
equivalently sized pieces. Each gel slice was cut up further into 1mmx1mm cubes and
washed with HPLC grade H2O. Pieces were incubated with 700µL desain solution
(50mM ammonium bicarbonate and 50% MeCN) for 30min at 37°C. Destain was
removed and pieces were subjected to dehydration by adding 100µL 100% MeCN for
20’. Gel pieces were further dried in a speed vacuum for 5’. Proteins were digested into
peptides using sequencing grade modified trypsin at a concentration of 12ng/µL in
50mM ammonium bicarbonate at 37°C overnight (16-18h). The following day, digests
were centrifuged at 12000xg for 1’ and supernatant was transferred to a 0.6mL tube.
50µL extract solution A (described below) was added to samples for 1h at room
temperature. Samples were centrifuged at 12000xg for 15’ and supernatant was
transferred to a 0.6mL tube (same tube as before). 50µL extract solution B (described
below) was added to samples for 1h at room temperature. Samples were centrifuged at
12000xg for 15’ and supernatant was transferred to a 0.6mL tube (same tube as before).
50µL 100% MeCN was added to tubes for 5-10’ at room temperature. Samples were
centrifuged at 12000xg for 15’ and supernatant was transferred to a 0.6mL tube (same
tube as before). Samples in 0.6mL tubes were dried in a speed vacuum for 3-4h and
stored at -80°C with proteomics facility.

63

2.8 Immunoprecipitations
For AKAP79 immunoprecipitations, SKOV-3 whole cell extract was first
treated as biotin transfer (previously described). Subsequently 100µg of protein was
incubated with 1.4µg anti-AKAP79 (sc-10764) antibody for 2h at 4°C followed by 1h
at room temperature. Immunocomplexes were incubated with protein G-magnetic beads
for 1h at room temperature, washed four times with RIPA lysis buffer, resuspended and
boiled in 40µL of 1x Laemmli sample buffer for 10’.
For RIIα immunoprecipitations, SKOV-3 or HEK293 100µg whole cell extract
was incubated with 1.4µg anti-RIIα (sc-908) antibody for 2h at 4°C. Immunocomplexes
were incubated with protein G-magnetic beads for 1h at 4°C, washed four times with
RIPA lysis buffer, resuspended and boiled in 50µL of 1x Laemmli sample buffer for
10’.
2.9 Western Blotting
For preparation of whole cell extract, cells were washed twice with ice-cold
complete Dulbecco’s phosphate buffered saline, then lysed in RIPA lysis buffer
(150mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl
sulphate, 50mM Tris, pH 8.0) containing protease and phosphatase inhibitors or mRIPA (0.25% sodium deoxycholate, 150mM NaCl, 1mM EDTA, 1.0% NP-40, 50mM
Tris, pH 8.0). After 10’ on ice, lysates were scraped into ice-cold microcentrifuge tubes
and centrifuged at 14,000 rpm (in an Eppendorf microcentrifuge) for 10’ at 4°C.
Protein concentration of the supernatant lysate was determined by bicinchoninic acid
assay (Pierce). For direct immunoblotting, aliquots of lysate were mixed with 5x
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Laemmli sample buffer and boiled for 10’ before loading on 10% or 7.5% SDS-PAGE
gels. Samples were separated with SDS-PAGE followed by transfer to nitrocellulose
membrane. Membranes were blocked with 5% nonfat dry milk powder in TBS 0.01%
Tween-20 for 1h at room temperature. Membranes were incubated with primary
antibody overnight at 4°C. Following incubation with primary, membranes were
washed in TBS with 0.01% Tween-20 (TBS-T) 5x 5’and incubated with HRPconjugated secondary antibody diluted in 5% nonfat dry milk in TBS-T, 1:1250 for 15’
at RT. Detection was performed using chemiluminescence (Pierce).
2.10 Streptavidin-HRP (sA-HRP) Blotting
For detection of biotinylated proteins using sA-HRP, a protocol was optimized
from Kyle Roux, Ph.D. at The University of South Dakota. Following transfer of SDSPAGE to nitrocellulose, membrane was incubated in BSA blocking buffer (recipe as
described below) for 20’-30’ shaking at room temperature. sA-HRP was added at
1:40,000 in 10mL BSA blocking buffer and incubated for 40’ at room temperature
shaking. Membrane washed 3-4x vigorously with 1xPBS over sink, followed by 5’
incubation with ABS blocking buffer (recipe described below), and 5’ incubation with
ABS+150mM NaCl shaking at room temperature. Membrane washed 3-4 times
vigorously with 1xPBS over sink. Membrane washed with 2x5’ 1xPBS+250mM NaCl,
followed by 2x5’ 1xPBS. Detection was performed using chemiluminescence (Pierce).
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2.11 Immunofluorescence
For visualization of ezrin, paxillin, FAK, RIIα, and lamin A/C, SKOV-3 cells
were plated on 10µg/mL fibronectin and were fixed in 3.7% formaldehyde in TBS for
10’, permeabilized for 10’ in TBS containing 0.25% triton X-100, and blocked with
TBS containing 3% BSA for 1h at room temperature. Cells were incubated with antipaxillin (1:500, BD Transduction), rabbit anti-RIIα (1:200, Santa Cruz Biotechnology),
mouse anti-ezrin (1:200, BD Transduction), mouse anti-lamin A/C (1:200, BD
Transduction), or rabbit anti-FAK (sc-558) overnight at 4°C in a humidity chamber.
The following day, cells were treated with Proximity Ligation Assay probes according
to manufacturer’s instructions.
For visualization of filamin A, SKOV-3 cells were plated on 10µg/mL
fibronectin and were fixed in pre-chilled anhydrous MeOH. Cells were incubated in 20°C for 20’. Cells were then treated with 3.7% formaldehyde in TBS for 10’ at RT,
blocked in PBS containing 1.5% BSA for 1h at room temperature. Cells were incubated
with mouse anti-filamin A (1:400, Millipore) overnight at 4°C. The following day, cells
were treated with Proximity Ligation Assay probes according to manufacturer’s
instructions.
2.12 In Situ Proximity Ligation Assay
Protein interactions in SKOV-3 cells were studied using an In situ Proximity
Ligation Assay Kit (Duolink®) from Sigma. Cells were plated on 10µg/mL fibronectin
coated coverslips and let adhere overnight. Cells were fixed, permeabilized, and
incubated with primary antibodies as described in immunofluorescence assays. The
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Proximity Ligation assay was used as recommended by the manufacturer. In short, cells
were incubated with secondary antibodies with attached nucleotides, including both
anti-rabbit and anti-mouse coupled to PLUS and MINUS nucleotides respectively. If
nucleotides were close (less than 30-40nm), and after ligation, a circular DNA strand
formed. After amplification of the DNA circle and hybridization of fluorescently
(563nm) labeled complimentary oligonucleotide probes, protein interactions were
visualized as red dots.
2.13 Coomassie Staining
Following electrophoresis, SDS-PAGE gels were stained in 0.006% Coomassie
Brilliant Blue R-250 (Bio-Rad) in 10% acetic acid for 1h. Destain solution (50mM
NH4HCO3 and 50% acetonitrile) was used for destaining for 12h, changing destain
periodically.
2.14 Lysis Buffers and Other Buffers
All buffers stored at 4°C unless otherwise indicated. Cytoskeleton Stabilizing
Buffer contained 10mM MES pH 6.1, 138mM KCl, 3mM MgCl, 2mM EGTA, 0.32M
sucrose, and 0.5% triton X-100. RIPA (150mM NaCl, 1.0% NP-40, 0.5% sodium
deoxycholate, 0.1% sodium dodecyl sulphate, 50mM Tris, pH 8.0) and modified RIPA
buffer (0.25% sodium deoxycholate, 150mM NaCl, 1mM EDTA, 1.0% NP-40, 50mM
Tris, pH 8.0) were used as indicated. RIIα purification lysis buffer contained 10mM
MOPS (pH 6.9), 100mM NaCl, 1mM DTT, protease and phosphatase inhibitors. BSA
blocking buffer contained 1xPBS with 1% bovine serum albumin and 0.2% (w/v)
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Triton X-100. ABS blocking buffer contained 1xPBS with 10% adult bovine serum, 1%
(w/v) Triton X-100, 150mM NaCl. Extract solution A (for mass spectrometry)
contained 5% formic acid. Extract solution B (for mass spectrometry) contained 5%
formic acid 50% MeCN.
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CHAPTER 3: Results
3.1 Results
3.1.1 Model for application of the biotin transfer method
There is surmounting evidence from our lab and others, demonstrating discrete
pockets of PKA activity at the leading edge of cells. Additionally, our lab has shown
that disruption of the AKAP-PKA interaction, with the use of anchoring disrupting
peptides, leads to a decreased ability of SKOV-3 cells to migrate (Mckenzie et al.,
2011). Therefore, we sought to generate a method for searching for and identifying
leading edge AKAPs, which may be responsible for type II anchoring of PKA, thus
responsible for the observed PKA activity. With the limitations and advantages of
classically used techniques, we created a method based on the use of purified PKA RIIα
and the use of a commercially available sulfo-SBED biotin transfer reagent (Fig. 1).
Because biotin is relatively uncommon in vivo, and it is amenable to selective isolation,
it became an obvious choice for the modification on which we chose to focus.
Sulfo-SBED

is

an

abbreviation

for

Sulfo-N-hydroxysuccinimidyl-2-(6-

[biotinamido]-2-(p-azidobenzamido)-hexanoamido) ethyl-1,3’-dithioprprionate. It is a
heterobifunctional chemical crosslinker, with an amine-reactive NHS ester group at one
end, capable of binding to any lysine group. On the other arm, there is a UV lightactivatable azide group, which crosslinks non-specifically to any protein side chains.
What makes this method distinguishable from other chemical crosslinkers, are the
biotin group and cleavable disulfide bond. Together, these groups lend the ability to
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Figure 1: Schematic for application of the biotin transfer reagent coupled to RIIα in SKOV-3
cells
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Figure 1: Schematic for the application of biotin transfer coupled to RIIα method
in SKOV-3 cells. RIIα was purified from BL21 PLysS (DE3) bacteria expressing
pET28(b)-RIIα(WT) and coupled to SULFO-SBED. Whole cell extract from SKOV-3
cells plated on 10µg/mL fibronectin was incubated with RIIα-sulfo SBED. Prior to
incubation with RIIα, lysate is incubated with 50µM Ht31 or Ht31P for 1h. UVactivatable azide group was crosslinked to putative AKAPs binding to RIIα with UVlight (365nm). 100mM DTT was used to reduce the disulfide bond, completing the
transfer from RIIα to its binding partners. Streptavidin beads were used to selectively
isolate biotinylated proteins.
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crosslink RIIα to interacting partners, and transfer the biotin affinity tag onto binding
partners. Selective pulldown of the biotin adduct using streptavidin-beads, allows the
isolation of binding partners and subsequent identification. This is a powerful in vitro
method for protein interaction discovery and has been used successful in the
characterization of novel protein interactions.
For our application, we wanted to enrich for PKA type II interactions with
AKAPs, and therefore made use of the ability to purify the PKA RIIα subunit.
Additionally, we anticipated treatment of lysate with our Ht31 disruptor peptide, would
result in disrupted PKA-AKAP interactions, preventing the transfer of the biotin
adduct. Based on the previous data, and the lab’s interest in cell migration, it is
conceivable to think the PKA activity is spatially regulated through an AKAP
intimately involved in cytoskeletal dynamics.

3.1.2 Characterization and optimization of the biotin transfer method
Because of the novelty of the technique, there were a number of optimizations
and characterizations that were necessary upfront. To determine if the sulfo-SBED
reagent worked with our application, purified RIIα from BL21, was coupled according
to the manufacturer’s directions. RIIα coupled and uncoupled to the sulfo-SBED were
analyzed by SDS-PAGE and blotting for biotin with streptavidin-HRP (Fig. 2A). As
expected, the uncoupled RIIα showed no presence of biotin, however the coupled RIIα
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Figure 2: Characterization and Optimization of Biotin Transfer Method
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Figure 2: Characterization and Optimization of Biotin Transfer Method. (A)
Purified RIIα either coupled to Sulfo-SBED or not, was analyzed by SDS-PAGE.
Streptavidin-HRP was used to detect the presence of biotin groups and detection of
multiple bands shows RIIα is not 100% pure. (B) SKOV-3 cells were plated on
10µg/mL and lysed in m-RIPA buffer. Biotin transfer method was done in 100µg
whole cell extract while control lane did not receive RIIα-sulfo SBED. Streptavidin
pull-down was done and following washes with RIPA buffer, biotinylated proteins
were eluted and separated by SDS-PAGE. Pull-downs were immunoblotted with αmouse AKAP79 antibody and whole cell extract was included for control. (C) Biotin
transfer method in 100µg whole cell extract from SKOV-3 cells with titrated amounts
of RIIα (1:100, 1:200, 1:1000, 1:2000 w/w RIIα:extract). A no RIIα control lane was
used additionally. Streptavidin pull-down was done and following washes with RIPA
buffer, biotinylated proteins were eluted and separated by SDS-PAGE. Pull-downs
were immunoblotted with α-mouse AKAP79 antibody and α-mouse tubulin antibody
and whole cell extract was included as a control. (D) Biotin transfer method in 100µg
whole cell extract from SKOV-3 cells with titrated amounts of streptavidin beads used
in pull-down (25µL, 50µL, 100µL). A no RIIα control lane was used additionally.
Streptavidin pull-down was done and following washes with RIPA buffer, biotinylated
proteins were eluted and separated by SDS-PAGE. Pull-downs were immunoblotted
with α-mouse AKAP79 antibody and α-rabbit RIIα (sc-908) antibody and whole cell
extract was included as a control.
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had multiple detectable bands, suggesting the coupling of sulfo-SBED to other proteins.
This suggested that the purity of the RIIα had been compromised. Given the specificity
of Ht31 for PKA-AKAP interactions, the purity of the RIIα was less concerning
although still provides substantial evidence for further optimization of the technique.
To determine if the biotin was successfully being transferred to a known AKAP,
we searched for the presence of the biotin group on a well characterized AKAP in the
presence or absence of the RIIα-Sulfo SBED. AKAP79 has been well described as a
canonical AKAP which binds to PKA RIIα through the conserved amphipathic helix
(Scott). As expected, the pull down with streptavidin beads revealed the biotin group on
AKAP79 only when lysate was treated with RIIα-sulfo SBED and not with purified
uncoupled RIIα (Fig. 2B). This supported the hypothesis that AKAP79 can only be
pulled down if the RIIα had successfully transferred a biotin group. This provided
strong evidence of the method working with our target interest group of proteins.
Additionally, to be sure we were detecting AKAP79 as a function of RIIα and it was
not alternatively selectively pulled-down by interacting with the beads, we examined
whether or not we could detect it in the absence of RIIα-sulfo SBED. The absence of
AKAP79 with no RIIα, suggested that it was in fact selectively pulled-down as a result
of biotin transfer from RIIα (Fig. 2B).
The conditions used in previously described experiments were based on initial
experiments done a number of years prior. As these conditions were not previously
optimized, there were justifiable grounds to do so. To examine the amount of RIIα
needed, the ratio of RIIα to lysate (w/w) was titrated. Additionally, there were some
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initial observations of non-specific proteins present in the pull-downs, suggesting
possibly the RIIα was in great excess and therefore non-selectively binding and
transferring biotin to a number of proteins in the cell. In order to reduce the signal to
noise ratio of specific RIIα binding partners to non-specific partners, RIIα amounts
were titrated in WCE (Fig. 2C). Pull-downs followed up with immunoblotting of both
AKAP79 and tubulin, specific and non-specific PKA binding partners respectively,
were used to assess biotin incorporation. The amount of AKAP79 selectively pulled
down dropped proportionally as a function of amount of RIIα as expected (Fig. 2C). By
contrast, no tubulin was detected as a function of streptavidin pull-down, suggesting no
biotin incorporation onto non-specific proteins. Additional immunoblotting of other
proteins not expected to bind RIIα, showed similar results as tubulin (data not shown).
In order to determine the optimal amount of streptavidin-beads to use in the pull
down, a similar titration was done varying the amounts of the beads relative to the
lysate. Consistent with previous results, we detected no AKAP79 in the no RIIα control
lane. Unexpectedly, we did not see an increase in the amount of AKAP79 selectively
pulled-down as a function of increasing the amount of beads (Fig. 2D).

3.1.3 Ht31 disrupts the AKAP79-PKA interaction in SKOV-3 cells
The Ht31 peptide has been well characterized as disrupting the PKA-AKAP
interaction. It has been widely used as a mechanism to study PKA anchoring (Scott et
al., 2013). Taken from a known AKAP, AKAP-Lbc, Ht31 contains the PKA R subunitbinding domain, the canonical amphipathic helix. We therefore we sought out to
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determine whether or not this peptide would disrupt RIIα-sulfo SBED interaction in
lysates, and thus lead to a decrease in the amount of biotin transferred to known
AKAPs. Using varying concentrations of Ht31, or the control peptide, Ht31P, we saw a
decrease in AKAP79 in our pull-downs in the presence of the disruptor peptide, but not
with the control peptide (Fig. 3A). Quantification of this shows over a two-fold
reduction is relative amounts of AKAP79 selectively pulled-down using streptavidin
beads (Fig. 3B). While 50µM showed the most significant decrease in amount of
AKAP79, there were concerns about the control peptide also disrupting the AKAPPKA interaction (Fig. 3A). While non-AKAPs were found in the pull-down, Ht31 did
not appear to have an effect on the amount of those proteins detected (data not shown).
These data suggested that Ht31 was in fact specifically disrupting the PKA-AKAP
interaction.

3.1.4 Interaction between Filamin A and RIIα in SKOV-3 cells
The search for leading edge AKAPs began a few years ago in our lab, and the
biotin transfer method had been previously applied to both cell body and pseudopods
(purified leading edge structures). Mass spectrometry data from the initial experiments
provided strong evidence for some potential and novel AKAPs that may be responsible
for the observed PKA activity at the leading edge. From this data set, the protein
identified with the most significant p-value, was Filamin A (FLNa), an actin-binding
protein intimately involved in actin cytoskeletal dynamics (Stossel et al., 2001;
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Nakamura et al., 2007). Showing both a strong reduction as a function of Ht31, and
strong biological relevance,
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Figure 3: Ht31 but not Ht31P disrupts RIIα-AKAP79 interaction in SKOV-3 cells
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Figure 3: Ht31 but not Ht31P disrupts RIIα-AKAP79 interaction in SKOV-3 cells.
(A) Biotin transfer method in 100µg whole cell extract from SKOV-3 cells treated with
titrated amounts of Ht31 or Ht31P (10µM, 25µM, 50µM) for 1h. Streptavidin pulldowns were done and following washes with RIPA buffer, biotinylated proteins were
eluted and separated by SDS-PAGE. Pull-downs were immunoblotted with α-mouse
AKAP79 antibody and whole cell extract as a control. (B) Relative densitometry is
depicted in the black bar graph.
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we attempted to characterize filamin A as a potential AKAP. Given filamin’s role in
mechanotransduction, myriad of over ninety binding partners, and dynamic regulation
over cytoskeletal dynamics, this was a very exciting finding.
Some of the initial sA pull down and co-immunoprecipitation experiments
showed strong evidence of an interaction between RIIα and FLNa. Even more, an in
silico approach identified a region in the N-terminus whose sequence has the potential
of forming an amphipathic helix (data not shown). This supported our hypothesis that
FLNa is a cytoskeletal AKAP. Therefore, to carry our investigation further, we sought
to

confirm

this

interaction

using

traditional

biochemical

methods.

Immunoprecipitations for both RIIα and IgG, as a control, were performed in both
HEK293 and SKOV-3 cells under varying conditions. Many results showed filamin A
present only with RIIα and not with IgG (Fig. 4A), supporting our hypothesis and
further suggesting an interaction between RIIα and FLNa. However, when
immunoprecipiations were repeated, different results were observed, showing filamin A
present in both the RIIα and IgG lanes, suggesting filamin A may not be specifically
interacting with RIIα (Fig. 4B). FLNa binding partners is comprised of 24
immunoglobulin-like domains, which have been described as inherently sticky, it is
plausible to believe that the observed interaction between filamin A and RIIα is nonspecific. AKAP79 is as a well described and canonical AKAP, therefore we were able
to use it as our positive control. Our data showed AKAP79 present only in the presence
of RIIα and not with IgG, supporting the ability of this technique to confirm AKAPs.
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Figure 4: Interaction between Filamin A and RIIα in SKOV-3 cells

82

Figure 4: Interaction between Filamin A and RIIα in SKOV-3 cells. (A)
Untransfected SKOV-3 cells were cultured on 10µg/mL fibronectin and lysed in RIPA
lysis buffer. 100µg of whole cell extract was treated for immunoprecipipation for PKA
RIIα or rabbit IgG as a control. Immunoprecipiations were separated by SDS-PAGE
and immunoblotted with antibodies against filamin A (FlnA), PKA RIIα, and AKAP79
as indicated. The positions of the molecular weight markers are indicated. (B)
Immunofluorescence detection of proximity ligation assay signal for filamin A/ RIIα
interaction in SKOV-3 cells after plating and fixing on 10µg/mL fibronectin.
Paxillin/FAK and ezrin/ RIIα were used as positive controls and FAK/Lamin A/C
interaction was used for negative control. Individual events of red PLA signal were
used as reading output. DAPI was used to stain nuclei (blue). Images were taken at a
magnification of 20x.
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Given that the observed results varied substantially and we were unable to
resolve the inconsistencies in the data, we sought to confirm this interaction using a
non-traditional approach. Proximity ligation assay was used to analyze the interaction
between RIIα and FLNa in SKOV-3 cells plated on 10µg/mL fibronectin. The
interaction between focal adhesion kinase (FAK) and paxillin (pxn) has been
extensively characterized and served as a positive control (Hildebrand et al., 1993).
Additionally, we used ezrin and RIIα as a positive control for AKAP-PKA interaction
as this interaction has been well described (Dransfield et al., 1997). FLNa and RIIα
showed a distinct pattern similar to what was observed in both positive controls (Fig.
4C). These data further supported our hypothesis that filamin A and RIIα interact and
that filamin A may be a potential novel AKAP.

3.1.5 Cytoskeletal fraction from SKOV-3 lysate shows enrichment of cytoskeletal
proteins
While the data confirming the RIIα FLNa interaction were inconsistent, the
RIIα AKAP79 data were strongly suggestive of the potential of using the biotin
transfer method as a successful method to identify AKAPs. Although the data was
inconclusive of filamin A being the potential AKAP responsible for leading edge PKA
activity, the question remained the same. We therefore sought out to repeat the biotin
transfer method, with a few modifications. Filamin A was originally found in protein
extracts isolated from pseudopods. However, pseudopodial preparations suffer from
several limitations, not at least of which is the recovery of very little protein.
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We sought out to selectively isolate the cytoskeletal fraction, to enrich for
potential cytoskeletal AKAPs. Borrowing methods from the literature (Avnur and
Geiger, 1981; Kuo et al., 2012), we fractionated lysate from SKOV-3 and isolated the
nuclei away from the cytoplasmic and cytoskeletal contents (Fig. 5A). The isolation of
focal adhesions has been well described (Kuo et al., 2012), and confirmation of their
isolation technique was confirmed using western blotting. We therefore chose protein
targets for immunoblotting, which should remain in distinct subcellular fractions in
order to confirm our method. Actin remained in the cytoskeletal fraction, after
cytoplasmic contents were collected; suggesting our cytoskeletal stabilizing buffer (see
Materials and Methods) was working as expected. While there was still actin remaining
in the nuclear fraction, this was likely due to the contamination from un-lysed whole
cells remaining (Fig 5B). Paxillin, a known focal adhesion protein, showed enrichment
in the cytoskeletal fraction compared to the nuclear fraction (Fig. 5B). Additionally,
GAPDH, a predominant cytoplasmic protein appeared to be enriched in the cytoplasmic
contents (Fig. 5B). Lamin A/C was used a marker for the nucleus, and showed
significant enrichment in the nuclear fraction, suggesting we were retaining nuclear
integrity during the cytoskeletal isolation (Fig. 5B). Taken together, these data
suggested we had a successful method for isolation of the cytoskeletal fraction. This
method however had little optimization, and further improvement could allow for a
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Figure 5: Cytoskeletal fraction from SKOV-3 lysate shows enrichment of cytoskeletal proteins
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Figure 5: Cytoskeletal fraction from SKOV-3 lysate shows enrichment of
cytoskeletal proteins. (A) Schematic of method used for cell fractionation and
cytoskeleton isolation. SKOV-3 cells were plated on 10µg/mL fibronectin and let
adhere for at least 24 h and cells were grown to ~90% confluence prior to lysis.
Cytoskeletal stabilizing buffer was added to cells to puncture the cell, removing
cytoplasmic contents. Cytoskeletal fraction is solubilized in RIPA and in-tact nuclei are
separated from cytoskeletal fraction by centrifugation. (B) 15µg of protein from each
fraction were separated by SDS-PAGE and immunoblotted with antibodies against
Lamin A/C, GAPDH, Paxillin, and Actin as indicated.
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greater isolation of the cytoskeleton from cytoplasmic and nuclear fractions. The
greatest challenge with this preparation is the amount of protein recovered from in the
cytoskeletal fraction. Consistently, protein yields were around 40µg from a 10cm dish
of confluent SKOV-3 cells.

3.1.6 Coomassie staining of streptavidin pull-downs from SKOV-3 lysate submitted for
mass spectrometry analysis
Both previous data and initial optimization of the biotin transfer method
suggested this was in fact a successful technique to identify AKAPs. We therefore
wanted to first apply this method to whole-cell extracts from SKOV-3. Due to the
technical difficulties involved with the cytoskeletal fractionation, we wanted to
establish a working system before proceeding to the application of the biotin transfer in
the cytoskeletal preparations.
To be sure that we were non-specifically pulling down proteins independently
of RIIα, we included a streptavidin (sA) pull down from whole cell extract excluding
RIIα. Streptavidin pull downs from whole cell extract were done in 150µg of protein in
the absence and presence of Ht31. While this amount much lower than those typically
used for mass spec analysis, observation of proteins via coomassie staining and advice
from the proteomics facility encouraged us to proceed using the pull-downs from
150µg (Fig. 6A). Three lanes were cut out of the gel, and subsequently cut into smaller
slices (see materials and methods). A tryptic digest was done following the instructions
provided by the proteomics facility and samples were submitted for analysis.
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Figure 6: Coomassie staining of streptavidin pull-downs from SKOV-3 lysate submitted for
mass spectrometry analysis

89

Figure 6: Coomassie staining of streptavidin pull-downs from SKOV-3 lysate
submitted for mass spectrometry analysis. (A) Whole cell extract from SKOV-3
cells plated on 10µg /mL fibronectin were lysed in m-RIPA buffer. Streptavidin pulldowns were performed in 150µg of whole cell lysates treated with RIIα-sulfo SBED for
45’ followed by treatment with or without 50µM Ht31 disruptor peptide for 1h. A
streptavidin pull-down in lysates not treated with RIIα was included as a negative
control. Pull-downs washed in RIPA buffer and eluent was separated by SDS-PAGE.
Samples were run on 10% gel and stained with coomassie true blue. 10µL of pull-down
supernatants was separated by SDS-PAGE and run alongside pull-down. (B)
Cytoskeletal fractions from SKOV-3 cells plated on 10µg/mL fibronectin were isolated
from cell extracts and pooled together. Streptavidin pull-downs were performed in
1000µg of cytoskeletal lysates treated with RIIα-sulfo SBED for 45’ followed by
treatment with or 50µM Ht31 or 50µM Ht31P for 1h. Pull-downs washed in RIPA
buffer and eluent was separated by SDS-PAGE. Samples were run on 10% gel and
stained with coomassie true blue. Gels were subsequently sliced, trypsinized, and
submitted for mass spectrometry analysis.
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After receiving the data from the facility, we were able to identify AKAP79, as well as
other known AKAPs (data not shown). Both AKAP79 as well as other known A-kinase
anchoring proteins, showed a decrease in number of peptides in the presence of Ht31,
supporting our hypothesis. Furthermore, after examining the dataset more closely, we
noticed that as expected, Ht31 had no observed effect on another family of proteins, the
annexins. These observations showed specific disruption of the PKA-AKAP
interactions. This suggested the method was working within our application, and
provided evidence to proceed using the cytoskeletal preparations. Concerned about
missed proteins due to low abundance and to achieve levels of bound proteins sufficient
for mass spectrometry, we scaled-up the amount of input from 150µg to 1000µg. Based
on the data from the no RIIα control, we decided to omit this from our second pull
down in an effort to save materials. Pooling together a number of cytoskeletal
preparations, we performed streptavidin pull-downs in the presence of either Ht31 or
the control peptide Ht31P (Fig. 6B). Coomassie staining showed both a decrease in total
number of bands and intensity of bands observed in the presence of the Ht31 peptide
compared to the Ht31P control peptide (Fig. 6B). Lanes were sliced and tryptic digests
were done as previously described for whole cell extract. Based on recommendations
from the proteomics facility, an additional alkylation and reduction step was done on
samples from cytoskeletal preparations. Peptides were extracted and subjected to liquid
chromatography tandem mass spectrometry in a linear ion trap mass spectrometer.
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3.1.7 List of candidate proteins selected from SKOV-3 cytoskeletal fraction and whole
cell extract
Mass spectra were analyzed using SEQUEST and Mascot and a concatenated
forward and reverse human NCI protein database approach (Elias and Gygi, 2007). Our
initial data analysis involved filtering of top SEQUEST peptide matches to around 1%
false discovery rate (described in materials and methods). In our whole cell extract
database, this method identified 3366 peptides and 3364 peptides in the absence or
presence of Ht31 respectively (data not shown). In the cytoskeletal fractions, we
identified 1636 and 1371 peptides in the presence of either Ht31P or Ht31 respectively.
This provided a very high stringency and confidence for protein identification. These
experiments were intended to act as a preliminary screen for AKAPs, which subsequent
biochemical methods would be required for confirmation of any potential hits. With
this in mind, we therefore decided to lower the stringency of which our proteins were
identified, to create a more comprehensive list of potential AKAPs. Following the
“high confidence” analysis, we lowered the cross-correlation scores (x-corr), which
facilitated SEQUEST peptide matches to >5% false discovery rate (see materials and
methods) and created a “low confidence” dataset (data not shown). In our whole cell
extract, this method identified 31273 and 33301 peptides in the absence and presence of
Ht31 respectively, while in the cytoskeletal fractions the method identified 30653 and
26915 proteins in the presence of Ht31P or Ht31 respectively. While the strength of the
mass spectra assignments was compromised slightly, the dataset generated is much
greater. This allowed us to identify known AKAPs, including AKAP79 which had been
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previously confirmed by immunoblotting (Fig. 2 and 3). Given the size of these
datasets, we needed a way to narrow down the proteins and select a list of candidate
proteins that are potential AKAPs.
Although Ht31 should ideally greatly disrupt PKA-AKAP interactions, there
was still evidence of AKAPs by mass spectrometry identification. Using total number
of peptides identified for a protein as an initial rubric, we sought to determine the
peptide fold-decrease from Ht31P to Ht31 for each protein (see materials and methods).
In order to trim the dataset further, the fold decreases or “displacement factor” were
sub-divided into four categories; x=100 x ≥ 50, 50>x>0, x=0, with x=100 representing
those proteins found exclusively in the presence of the Ht31P control peptide.
Simultaneously, proteins were analyzed using PANTHER Gene Ontology and sorted by
protein class. Comparing proteins with a “displacement factor” between 50 and 100 to
the gene ontology protein class, a list of candidate proteins was generated subjectively
(Table 1). While this protein list was chosen relatively arbitrarily, particular attention
was paid to protein class and included only those proteins labeled by PANTHER as
“cytoskeletal”, “cell adhesion/cell junction”, or “signaling”. Additional proteins were
included if they had a significant “displacement factor” and were known to interact
with cytoskeletal proteins (eg. filamin A-interacting protein 1). The number of peptides
identified was included in this list to allow for another level of stringency, as proteins
with 1 or lower peptides identified were removed from the list. The datasets were
scanned and searched for known A-kinase anchoring proteins. In some cases, the
identification of these varied between the datasets. This provided internal positive

93

controls for what the data should represent for known AKAPs. A number of proteins
identified from the “cytoskeletal fraction” were known DNA binding proteins, nuclear
proteins, and a number of cytoplasmic proteins. The presence of these clearly suggests
the need for improvement and optimization in the fractionation technique.
The list of candidate proteins was of particular interest as one of the proteins
which showed the highest “displacement factor” was in fact filamin A. Additionally,
there were a number of canonical focal adhesion and cytoskeletal proteins which
showed both a large number of identified peptides and a large “displacement factor”.
Of particular interest is talin-1, which was previously identified from the initial screen
(Howe and Baldor unpublished data) in addition to well characterized cytoskeletal
AKAPs such as ezrin. To this point, we have established a list of potential AKAPs
which may be responsible for the spatial regulation of PKA activity during cell
migration and adhesion. Additionally, these data suggest that we have a method to
selectively isolate PKA RIIα binding partners from SKOV-3 cells.
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Table 1: Identification of candidate proteins selected from SKOV-3 cytoskeletal fraction and
whole cell extract
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Table 1: Identification of candidate proteins selected from SKOV-3 cytoskeletal
fraction and whole cell extract. Subjectively selected proteins chosen from complete
dataset from mass spectra analysis, as described in materials and methods, for both
whole cell extract and cytoskeletal fraction. Dataset indicates which subsequent table
protein can be found. IPI number represents accession numbers from the International
Protein Index. Displacement factor represents the fold change as a function of Ht31;
calculated as the difference in number of peptides between Ht31P sample and Ht31
relative to number of peptides in Ht31P sample as identified by the mass spectrometer.
Displacement factor was binned according to materials and methods, x≥50 (green),
50>x>0 (orange), 100 indicates those unique to Ht31P (blue). Mass spec strength
correlates to the filters and xcorr scores used to filter the protein datasets. PANTHER
protein class refers to the gene ontology as indicated by the PANTHER database.
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3.1.8 Development and Rationale of Algorithm
Based on the criteria included in our selected list, we sought to determine a less
subjective approach to selectively identify potential AKAPs from our large dataset. We
therefore generated an algorithm which uses the criteria from table 1, and creates a
score for each of the potential candidates (Fig. 7). Using the same algorithm, we scored
known AKAPs to establish a range of numerical values in which we would expect
potential AKAPs to lie.
The criteria included in the algorithm are as follows: “displacement factor”,
biological relevance, mass spec strength, total number of peptides in Ht31P, AKAP
consensus site, and helical projection of the AKAP consensus site. Of these criteria,
some are more important and therefore carry more weight in the algorithm. Given that
the Ht31 peptide should displace all canonical PKA-AKAP interactions, the most
weight was given to those proteins which showed the greatest decrease in number of
peptides in the presence or absence of the Ht31 inhibitor peptide. This is referred to as
the “displacement factor”, which represents the difference in number of peptides found
from the Ht31P to Ht31 treatments, divided by the total found in the Ht31P treatment,
and was given the most weight in the algorithm. Biological relevance was determined
based on PANTHER Gene Ontology information, assigning numeric values to
candidate proteins found in the following PANTHER protein classes: cytoskeleton,
signaling, junction, and adhesion. Biological relevance was given the second highest
priority in the algorithm. Both mass spectrometry strength and total number of peptides
found in the Ht31P experimental lane were given equal priority. Mass spectrometry
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Figure 7: Development and Rationale of Algorithm to

99

Figure 7: Development and Rationale of Algorithm. (A) Algorithm used to assign a
numerical score to candidate AKAPs. Certain criteria given higher weight are indicated
by the numerical coefficient. (B) List of criteria included in the algorithm. Numerical
values assigned as indicated. Displacement factor represents the difference in total
number of peptides found in the Ht31 compared to Ht31P treatments, divided by the
total number of peptides found in the Ht31P treatment. Biological relevance was
determined using the protein classes as assigned by PANTHER Gene Ontology
database. Mass spectrometry strength either indicated as high or low, was determined
by x-correlation values and peptide confidence as determined by the Thermo Proteome
Discoverer software. AKAP consensus site used in search was the following:
(AVLISE) XX (AVLIF) (AVLI) XX (AVLI) (AVLIF) XX (AVLISE) where X
represents any amino acid. Predicted helix structure determined using software through
The University of Virginia.
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strength was either considered “High” and assigned a numerical value of 2, or “Low”
and assigned a numerical value of 1. “High” and “Low” refer to the strength of the
cross-correlation scores and peptide confidence as described previously. Finally, the
identification of an AKAP consensus site and the likelihood that site forms a canonical
helix were included in the algorithm. The identification of an AKAP consensus site was
done using an in-silico approach in conjunction with Benjamin King. The helical wheel
structure was predicted using a helical wheel projection application found through the
University of Virginia. Helical wheel structure was assigned a value of 2 for “yes” and
1 for “no” based on the likelihood the AKAP consensus site would form a helix. AKAP
consensus site was assigned a numerical value of 3 if a potential site was identified and
1 if there was no site. A value was still assigned even if no AKAP consensus site was
identified because of the potential the candidate protein could be a non-canonical
AKAP, binding PKA through an alternative mechanism.

The following AKAP

consensus site was used in the search: (AVLISE) XX (AVLIF) (AVLI) XX (AVLI)
(AVLIF) XX (AVLISE) where X represents any amino acid.
We applied the algorithm described above and looked at some known A-kinase
anchoring proteins, some of which are also known to be involved in cytoskeletal and
adhesion dynamics (Table 2). Gravin, WAVE1, AKAP-Lbc, and ezrin, are known
cytoskeletal-associated proteins which have also been confirmed as AKAPs. AKAP 5
(AKAP79) and AKAP11 were used to generate values for other known AKAPs, that
are not cytoskeletal or adhesion proteins. These gave us a numerical range for where we
would expect to see other potential cytoskeletal and adhesion associated AKAPs.
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Table 2:Score for Known A-Kinase Anchor Proteins Using Developed Algorithm
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Table 2: Score for known A-kinase anchoring proteins using the developed
algorithm. Using the algorithm as described in figure 7, known AKAPs were scored.
Gravin (AKAP12), ezrin, WAVE1, and AKAP-Lbc (AKAP13) are known cytoskeletal
and adhesion associated proteins. AKAP 5 (AKAP79) and AKAP11 are other known
AKAPs which have not been described as involved with cytoskeletal and adhesion
dynamics.
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CHAPTER 4: Discussion
A-kinase anchoring proteins (AKAPs) are scaffolding proteins which contribute
to cAMP signaling pathways through tethering of the cAMP dependent kinase A
(PKA). AKAPs target PKA to discrete subcellular compartments, as well as
simultaneously binding multiple other proteins to create large and integrated signaling
complexes. In this way, AKAPs tightly coordinate and highly localize PKA with its
target substrates as well as its effectors, to allow for a tight regulation of PKA-mediated
signaling events distributed around the cell. AKAPs provide temporal and spatial
regulation and specificity and therefore are essential to mediating a number of cellular
effects among many diverse biological processes, one of which is cell migration.
Cell migration plays a crucial role in many aspects of cellular biology and
subsequently healthy physiology and misregulation can lead to many diseases,
including cancer metastasis. Successful cell migration requires the organization and
coordination of many complex processes the least of which are is integrin activation,
cytoskeletal rearrangements, and turnover of adhesive structures (Howe, 2011). The
cell’s migration machinery must therefore be tightly regulated by signaling proteins
which can efficiently convert upstream stimuli into diverse and multiple downstream
effects. Additionally, complexity of cell motility requires its regulation be controlled by
a multi-faceted enzyme which is able to integrate multiple pathways with migration
dynamics. The role of the cAMP-dependent kinase A is perhaps the best example of
such a regulator. PKA has been well studied as a regulator of cell migration, exerting
both positive and negative effects (Howe, 2004), and has a number of substrates
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involved in cytoskeletal organization, adhesion dynamics, and in general cell migration
(Howe, 2004). Given the important role of PKA in cell migration, the goal of the
enclosed work was to identify potential AKAPs which may be responsible for
regulating the pools of PKA activity involved in cell migration.
Work in our lab has demonstrated the enrichment of discrete pockets of PKA
activity in the leading edge of migrating cells (Mckenzie et al., 2011; Howe et al.,
2002) and this activity is both required for migration and focal adhesion dynamics
(McKenzie unpublished data). This data is corroborated by observations that disrupting
PKA anchoring inhibits the cell’s ability to form leading edge structures, retain proper
focal adhesion dynamics, and migrate effectively. These data underscore the
importance of AKAPs in the processes of cell migration and provide molecular insight
into important aspects of cell migration. While these and other data established the
complex, dynamic, and important role for PKA in cell migration, PKA exerts many
other effects within the cellular context. Therefore, there is a need for localizing and
specifying PKA activity to sites of cytoskeletal and adhesion dynamics to allow PKA to
exert its effects on any number of its adhesion and migration-associated substrates
(Howe, 2004). The goal of this body of work focused on identifying migration and
adhesion-associated AKAPs. Considering the adhesion and migration machinery
largely impinges on cytoskeletal dynamics and integrin activation, we chose to enrich
for the proteins involved in these processes with the hope of identifying potentially
novel AKAPs.
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Dissecting the molecular pathway and regulation of PKA activity within the
leading edge remains to be the focus of our lab, one aspect of which is identifying
cytoskeletal AKAPs. The question of which AKAPs are responsible for localized
leading edge PKA activity during cell migration remains to be answered. This body of
work presents a novel method for the identification of potential AKAPs in vitro. While
there have been reports of large screens to identify novel AKAPs, this work represents
the first report of a search for cytoskeletal-specific AKAPs which may be responsible
for leading edge PKA activity. Furthermore, this study provides sufficient evidence for
further exploration of cytoskeletal proteins not yet identified as AKAPs, and whose
contribution to cell migration have yet to be elucidated. Not only did this study propose
potentially novel AKAPs, but it also provides evidence for further exploration of
known AKAPs, whose contributions to cell migration have yet to be understood.
Several AKAPs have been identified as interacting with the cytoskeleton and
adhesive structures. For example, gravin/AKAP12/SSeCKS, ezrin/radixin/moesin
family, AKAP-Lbc/AKAP13, and Wiskott-Aldrich syndrome/verpolin protein family
members 1 and 2 (WAVE1 and 2). These reports however focus mostly on loss-offunction effects broadly within the cellular context and do not examine the specific
effects on PKA signaling with respect to cell migration. Indeed, the functional
consequence of disrupting PKA anchoring and have yet to be elucidated. In fact, these
studies focus on the phenotypic effect of loss of PKA activity and fail to identify the
discrete targets which are effected by the loss both PKA anchoring and activity.
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As part of their role, AKAPs are responsible for assembling and integrating
large signaling complexes, recruiting multiple binding partners, and anchoring PKA in
proximity to its targets (Scott et al., 2013). One hypothesis that arises is that PKA could
regulate migration and adhesion through the direct phosphorylation of key proteins
involved in these processes, and in fact there have been observations showing direct
PKA phosphorylation of adhesion and migratory proteins including but not limited to
VASP, α4 integrin, and filamin A (Dopler and Storz, 2013; Yeo et al., 2011; Howe,
2004). However, the effects on these PKA substrates as a result of disrupting the PKAAKAP interaction have yet to be identified. These observations would provide an
important insight into the potential mechanism by which PKA regulates migration
through anchoring.
This body of work identified exciting and potential novel cytoskeletal-AKAPs,
whose role in PKA anchoring and cell migration has yet to be elucidated. Not only can
AKAPs can contribute to cell processes through anchoring of PKA, but they can
contribute independent of anchoring function. In fact, a number of proteins with a
defined cellular role have been subsequently identified as AKAPs (Diviani et al., 2000;
Klussman et al., 2011; Alto et al., 2002; Lim et al., 2008). This provides evidence that
a number of AKAPs potentially involved in cell migration have yet to be identified.
Additionally, this provides ground for further characterizing and delineating their
contribution to cell migration, defining the potential molecular targets of PKA, and the
effects on those targets as a result of disrupting PKA anchoring.
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Much of the work done in examining the role of PKA anchoring with respect to
cell migration has been done by global inhibition of anchoring, through knockdown or
knockout models. Therefore making it difficult to delineate the contributions of specific
AKAPs. A better understanding of these specific contributions could be substantially
advanced through selective disruption of PKA-anchoring interaction. Deletion mutants
within the dimerization domain of RIIα, Δ2-5, have been extensively used and well
characterized (Kinderman et al., 2006). This study provides an elegant platform for
further characterization of specific AKAPs and their role in cell migration.
Considering the differential roles for the previously identified cytoskeletal
AKAPs, the extensive list of cytoskeletal associated PKA substrates, and the diversity
of both type I and II PKA anchoring, it is likely that there are multiple AKAPs which
contribute to the regulation of PKA activity during cell migration. Furthermore, it is
now clear that multiple AKAPs are even localized to the same subcellular compartment
(Colledge and Scott, 1999; Edwards and Scott, 1999). It would be prudent to assume
that while there is a potential for multiple, yet distinct AKAPs to play a role, there are
likely significant overlapping targets and functions. Additionally, given the differential
role of both PKA activation and regulation in cell migration and cell adhesion, it is
likely that distinct AKAPs are involved in these processes.
With that in mind, we have identified a number of proteins, which are of
particular interest and warrant further investigation. Filamin A was identified both in
this screen as well as in prior investigations. As an actin-crosslinker and
mechanosensitive protein (Razinia et al., 2012), filamin A is very enticing as a potential
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AKAP involved in cytoskeletal dynamics and cell migration. While this was a formal
hypothesis, attempts at characterization of the filamin-RIIα interactions were
technically challenging. Evidence from both biochemical and in silico data has strongly
shown the potential of filamin A as an AKAP, with the exciting identification of an
AKAP-consensus site (Hundsrucker et al., 2010) forming the classic amphipathic helix
(data not shown). However structure information that was released during the time of
this investigation showed this sequence to be involved in substantial protein secondary
structure. More specifically, the potential AKAP sequence is deeply embedded in a βbarrel of one of the 24 immunoglobulin domains that comprise filamin A, making the
likelihood of forming the canonical helix strongly unlikely. However, this does not
exclude the formal possibility of conformational rearrangement of the protein, leading
to the sequence releasing from its β-barrel and thus forming a helix to facilitate PKA
binding. Given filamins mechano-properties, a hypothesis that arises from these data is
that force and tension create strain across filamin A, causing conformational
rearrangements, and lead to the exposure of cryptic binding sites. Thus as a function of
tension, there is differential binding of proteins to filamin A (Chen et al., 2009;
Rognoni et al., 2014; Rognoni et al., 2012). In fact, it was shown through the use of
some very elegant biophysical techniques that applying mechanical force across filamin
A can expose the integrin binding site on IgFLNa21 (Ruskamo et al., 2012; Pentikainen
and Ylanne, 2009). These forces are of physiologically importance since filamin A is
subjected to forces from the cytoskeletal network of actin filaments, as well as the
extracellular forces conveyed through integrins.
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Consistent with the hypothesis that filamin A may be an AKAP, it is plausible
to assume that PKA binding could be regulated through a similar mechanism. This
would provide a beautiful integration of tension to PKA-mediated signaling events and
one, which is tightly controlled. Given the lab’s focus on mechanotransduction of PKA
activity at the leading edge of migrating cells, filamin A would be an ideal candidate
for contributing in this process.
Although identifying filamin A as a mechanosensitive AKAP involved in cell
migration would contribute significantly to the fields of cell migration and
mechanobiology, there are other potential proteins which are of similar excitement.
Using a largely subjective approach to screen the mass spectrometry data, this study
identified a number of proteins of biological relevance and showed disruption with the
Ht31 peptide. While this is a good starting point for further investigations, it is not
unlikely that a number of proteins were missed using this screen. There have been
reports of “noncanonical AKAPs” including pericentrin and α4 integrin whose RIIBD
is distinct from the amphipathic helix highly conserved across known AKAPs (Diviani
et al., 2000; Lim et al., 2008). Furthermore, these reports have shown that 50uM Ht31
does not disrupt the PKA-AKAP interaction, which provides evidence that our screen
could be missing other such noncanonical AKAPs. Additionally, our lab has shown that
PKA activity is localized to the leading edge of neuronal cells, a pool of which is
resistant to disruption suggesting further evidence of PKA localization through
noncanonical AKAP mechanisms (Rivard et al., 2009).
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Given the large and likely possibility of both false positives and false negatives
resulting in potentially missed proteins, there is obvious need for improvement and
optimization of this method. The biotin transfer method was intended as a preliminary
screen, the list of identified proteins was not to be directly published, but instead
provided primary evidence to warrant further biochemical methods for confirmation.
Therefore although there was some optimization prior to the pull-downs, errors in
experimental design could be tolerated due to the more stringent nature of the analysis
with the dataset. For example, the observed contaminations in our purified RIIα sample
were likely subjected to the same coupling to sulfo-SBED, allowing proteins other than
RIIα to be capable of biotin transfer. However, the specificity of Ht31 for PKA-RIIα
interactions provides an intrinsic way of distinguishing canonical AKAPs from other
non-specific proteins containing a biotin group transferred from either RIIα or other
contaminants.
The list of candidate proteins contained in this thesis was as previously
mentioned, subjectively chosen. The extensive list of proteins identified by mass
spectrometry provides evidence for further optimization. The PANTHER gene
ontology database provides an excellent way to group proteins by class, and should be
expanded upon further as a way of eliminating proteins. An algorithm was developed
(Fig. 7) as a way of objectively screening the list of hits for potential candidates. This
takes into account the criteria that were used in the subjective screen, and by adding a
numerical coefficient, we were able to weight different criteria more heavily than
others. While this is a general first attempt at an algorithm, a better algorithm will need
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to be developed. Each of the proteins were scanned to determine if any contained the
canonical AKAP consensus site. While the presence of a site is included in our
algorithm this does not exclude the fact that there may be others AKAPs which bind
PKA through an alternative and non-canonical method of binding, which has been seen
for other proteins (Howe, Waterman). Using this alogorithm and applying it to known
AKAPs, we have generated a numerical range of scores which we can use to compare
to those scores generated from the list of potential candidate proteins.
Within the list, talin-1 stood out as potentially interesting not only because it
had a substantial effect from the Ht31, but also because it was previously identified in
the original dataset. An in silico search for the AKAP consensus site
(AVLISE)XX(AVLIF)(AVLI)XX(AVLI)(AVLIF)XX(AVLISE) indicated a possible
site in the c-terminus, which also showed the formation of an amphipathic helix. Talin
is of particular interest because of its involvement in integrin activation and its role as a
scaffolding protein in focal adhesions, providing a link from integrins to the actin
cytoskeleton (Kanchanawong et al., 2010). Talin-1 was also found in a recent screen
for AKAPs (Hundsrucker et al., 2010). Taken together, this provides substantial
evidence to characterize the interaction with RIIα using traditional biochemical
methods. A number of cytoskeletal and adhesion-associated proteins were identified as
having a substantial effect from the Ht31, providing good support of our hypothesis.
Not only did we create a list of potentially uncharacterized and novel AKAPs,
other known AKAPs were identified. There is merit in their identification beyond
acting solely as a positive control. The role of AKAPs in cell migration has been only
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conceptually linked yet the contributions and regulations from specific AKAPs on cell
migration is not yet understood. Therefore, their identification within our mass
spectrometry data provides evidence for further elucidating their role in cell migration.
Ezrin and moesin, members of the ERM family, have been implicated as cytoskeletalassociated proteins however their role in cell migration has only begun to be explored.
The mechanisms by which ezrin affect migration and adhesion still remains unclear.
Additionally, gravin (AKAP12) has only minimally been described with respect to cell
migration (Akakaura and Gelman, 2012). Gravin has been shown to play diverse
functions from cytoskeletal rearrangements (Gelman, 2010) to direct involvement with
the beta2 adrenergic receptor however whether or not these functions are regulated by
PKA has yet to be described.
Of the known cytoskeletal AKAPs, AKAP-Lbc (AKAP13) has perhaps been
best understood with respect to cell migration. Recently, AKAP-Lbc was found to be
responsible for playing a substantial role in formation of PKA activity gradients
(O’Connor et al., 2012). Additionally, AKAP-Lbc was identified as a RhoA regulator,
specifically as a guanine nucleotide exchange factor (Diviani et al., 2006). While these
observations begin to delineate the role of AKAP-Lbc in migration, they focus on this
role with respect to the guanine exchange factor function of AKAP-Lbc instead of its
function as a PKA anchoring protein. WAVE1 was one of the first cytoskeletal
associated AKAPs and functions as a scaffolding protein to couple Rho GTPases to the
Arp2/3 complex, regulating actin polymerization (Diviani et al., 2006). WAVE1 has
been found to play a critical role in cell migration through actin reorganization.
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However, similar to ezrin and gravin, the contribution to cell migration through PKA
anchoring has yet to be defined. Taken together, this establishes the need to define
cytoskeletal AKAPs responsible for regulating PKA activity and contributing to cell
migration.
While this study was successful in identifying potential cytoskeletal AKAPs,
there are a number of experiments needed to confirm and characterize any of the
candidates as a bonafide AKAP. As mentioned earlier, there are in silico approaches
that although they have their limitations, can provide both a quick and inexpensive way
to search for AKAP consensus sites. Traditional biochemical approaches should be
taken which can serve to confirm the binding to RIIα. Co-immunopreicipatations, when
including the proper controls, can be powerful mechanisms to assess binding. Not only
can Ht31 and Ht31P be used within this context, but evoking the use of the RII deletion
mutant (Δ2-5) and other deletion mutants, can help to characterize interactions while
mapping particular regions of binding. In vitro binding experiments can allow for the
confirmation of protein-protein interactions, eliminating any problematic experimental
conditions, and further elucidating whether or not the interaction is direct or indirect.
Given the integrity and accessibility of purified proteins, these are relatively
inexpensive.
Beyond confirming the interaction, there are a number of additional experiments
that would be provide functional significance to any potential candidate. Given the labs
interest in PKA’s role in regulating cell migration and adhesion dynamics, another facet
to identifying new cytoskeletal AKAPs is to identify the discrete targets of PKA whose
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phosphorylation is regulated through AKAP binding. Identifying these PKA substrates
can be done through a number of biochemical approaches such as performing
phosphoproteomics on samples treated with PKA inhibitors and effectors as well as
general immunofluorescence. Cytoskeletal and focal adhesion proteins can be enriched
using similar methods as presented in this text. Mutagenesis studies could be used to
follow up potential candidates to confirm the precise role of PKA phosphorylation.
Considering the canonical role AKAPs play in targeting PKA and organizing signaling
complexes, determining the discrete PKA targets effected by disruption of PKA
anchoring would be provide important insight into the molecular mechanisms of PKAmediated cell migration.
After potential cytoskeletal or adhesion-associated AKAPs are identified, and
characterized, further experiments would be required to determine a functional role in
cell migration. A number of approaches could be taken at this juncture. Given the lab’s
expertise with the FRET-based PKA activity reporter, the contribution of identified
AKAPs within our cell migration model could be examined in this context. Deletion
mutants in candidate proteins would be particularly interesting, given they would
provide insight into the effects of specifically disrupting PKA anchoring compared to
broad scale anchoring disruptors (Ht31, sAKAP-is, RIAD). Migration assays, such as
the lab’s well used ‘donut’ assay and wound healing assays would be additional studies
to examine the specific role in cell migration.
A parallel project in the lab in collaboration with Neil Sarkar, Ph.D., is looking
at identifying potential PKA phosphorylation sites in adhesion and integrin associated
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proteins, using an in-silico approach. This approach may provide evidence of groups of
proteins which contain a PKA phosphorylation site, clustered around a single protein,
either through direct or indirect binding. Given that many known AKAPs are
scaffolding proteins, we hope to combine the data generated with Neil, with our
candidate protein list and look for any proteins which overlap. Any protein from our
candidate list which also interacts with a number of proteins containing PKA
phosphorylation sites, provides strong evidence as a potential AKAP. A preliminary
screen using Talin-1, identified a number of interacting partners which also contain a
known PKA phosphorylation site. This provides strong evidence that talin-1 may in fact
be the AKAP responsible for anchoring PKA and placing it within close proximity to
its target substrates.
We and others have shown the critical role for PKA in cell migration and
adhesion. Our laboratory has additionally established the importance of PKA anchoring
for migration however; the specific AKAPs responsible have yet to be identified.
AKAPs, as scaffolding proteins, are able to bind both kinases and phosphatases, and an
interesting hypothesis is that AKAPs may function as central regulators of the activity
of signaling complexes in space and time. Specifically, this dual binding ability could
enable AKAPs to regulate the phosphorylation of PKA substrates, providing transient
pockets of PKA activity. Identifying the specific cytoskeletal AKAPs involved in
leading edge PKA activity, associated PKA substrates, and the functional consequences
of disrupting PKA-AKAP interactions is essential to understanding the role of PKA in
cell migration and is an ongoing investigation. Given that misregulation of cell
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migration often leads to cancer and cancer metastasis, understanding the contributions
of the PKA-AKAP interaction can provide insight into a potentially interesting
mechanism for the development of targeted therapeutics.
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